{
  "meta": {
    "title": "70_Respiratory_Infections",
    "url": "https://brainandscalpel.vercel.app/70-respiratory-infections-3be5a456.html",
    "scrapedAt": "2025-11-30T06:57:37.100Z"
  },
  "questions": [
    {
      "id": 76166,
      "choices": [
        {
          "id": 216705,
          "text": "Posterior segment of right upper lobe"
        },
        {
          "id": 216706,
          "text": "Inferior lingular of left upper lobe"
        },
        {
          "id": 216707,
          "text": "Apical of Left lower lobe"
        },
        {
          "id": 216708,
          "text": "Posterior segment of Right lower lobe"
        }
      ],
      "text": "A bed-ridden patient on liquid diet develops aspiration pneumonia resulting a lung abscess. Which of the following is bronchopulmonary segment is most likely affected",
      "unique_key": "Q8908978",
      "question_audio": null,
      "question_video": null,
      "map_id": 34521648,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Posterior segment of right upper lobe. Aspiration pneumonia typically occurs when food, liquid, or other foreign materials are inhaled into the lungs, leading to infection. The right lung is more commonly affected in aspiration pneumonia due to its anatomical structure. The right mainstem bronchus is more vertical, shorter, and wider compared to the left, making it easier for aspirated material to enter the right lung, particularly into the right upper lobe. The posterior segment of the right upper lobe is the most common site for aspiration pneumonia because aspirated material often tends to settle in the upper segments of the right lung due to gravity, especially in a bedridden patient who is at higher risk for aspiration while lying down. This segment is more likely to be affected by lung abscess formation due to the infection following aspiration. Incorrect Options: B. Inferior lingular of left upper lobe (incorrect): While aspiration can also affect the left lung, it is less common in the left upper lobe, particularly the lingular segment, when compared to the right lung. The left mainstem bronchus is more angled and longer than the right bronchus, making it less likely for aspirated material to enter the left lung. Additionally, the lingula is located in a relatively dependent region of the lung, but aspiration typically favors the right side due to gravity. Therefore, this option is incorrect. C. Apical of Left lower lobe (incorrect): The apical segment of the left lower lobe is anatomically located in a less dependent area, which makes it a less common site for aspiration pneumonia, particularly in a bedridden patient. The lower lobes are more often affected than the upper lobes when aspiration occurs while the patient is in a supine position, but the left lower lobe does not commonly see infection in the apical segment in cases of aspiration. This makes this option incorrect. D. Posterior segment of right lower lobe (incorrect): The posterior segment of the right lower lobe is also a common site for aspiration pneumonia, but it is not the most typical site for lung abscess formation in a bedridden patient. The right upper lobe is more commonly involved, especially in the posterior segment, due to the ease with which aspirated material enters this area. While the posterior segment of the right lower lobe may also be affected, it is less likely to develop a lung abscess compared to the right upper lobe in this scenario. Therefore, this option is incorrect.",
      "correct_choice_id": 216705,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76167,
      "choices": [
        {
          "id": 216709,
          "text": "Legionella"
        },
        {
          "id": 216710,
          "text": "nesseria meningitis"
        },
        {
          "id": 216711,
          "text": "streptococcus pneumonia"
        },
        {
          "id": 216712,
          "text": "klebsiella pneumonia"
        }
      ],
      "text": "A 28 yr female had diarrhoea, confusion, high grade fever with bilateral pneumonitis. The diagnosis:",
      "unique_key": "Q4601358",
      "question_audio": null,
      "question_video": null,
      "map_id": 34537202,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Legionella. Legionella pneumonia, caused by Legionella pneumophila, often presents with a combination of symptoms such as high-grade fever, confusion, diarrhea, and bilateral pneumonitis (inflammation of the lungs). This condition is known as Legionnaires' disease. The presence of gastrointestinal symptoms (diarrhea), along with confusion and bilateral lung involvement, is highly suggestive of Legionella infection, which often presents with atypical pneumonia. It can also cause multi-organ involvement, including hepatic dysfunction, and is commonly acquired through inhalation of contaminated water vapor, such as from air conditioning systems or hot tubs. Incorrect Options: (B) Neisseria meningitis: Neisseria meningitidis is the causative agent of bacterial meningitis, which typically presents with symptoms such as fever, headache, neck stiffness, and altered mental status (e.g., confusion). While it can lead to sepsis, it is not associated with diarrhea or bilateral pneumonitis as primary features, making it an unlikely cause in this case. (C) Streptococcus pneumoniae: Streptococcus pneumoniae is a common cause of community-acquired pneumonia (CAP), but it typically presents with fever, cough, and unilateral consolidation on chest X-ray, not with the combination of diarrhea, confusion, and bilateral lung involvement. While it can cause severe infections, it does not typically present with the broad range of symptoms described here. (D) Klebsiella pneumoniae: Klebsiella pneumoniae is often associated with severe, lobar pneumonia, typically in patients with underlying lung disease, alcohol use disorder, or immunocompromise. It is more likely to cause a localized, rather than bilateral, infection and does not commonly present with gastrointestinal symptoms like diarrhea. While it can cause severe pneumonia, the clinical picture in this case is more consistent with Legionella.",
      "correct_choice_id": 216709,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76168,
      "choices": [
        {
          "id": 216713,
          "text": "Most patients have CD4 counts <200 cells per μL at the time of diagnosis of their first episode of P. jiroveci pneumonia."
        },
        {
          "id": 216714,
          "text": "Most patients with P. jiroveci pneumonia will have an elevated serum lactate dehydrogenaselevel."
        },
        {
          "id": 216715,
          "text": "Arterial blood gases in patients with P. jiroveci pneumonia frequently reveal respiratory alkalosisand a widened alveoloarterial oxygen tension difference."
        },
        {
          "id": 216716,
          "text": "A normal chest radiograph rules out the diagnosis"
        }
      ],
      "text": "Regarding Pneumocystis jirovecipneumonia in HIV-infected patients, which of the following statement is false?",
      "unique_key": "Q7288092",
      "question_audio": null,
      "question_video": null,
      "map_id": 34701661,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) A normal chest radiograph rules out the diagnosis. In patients with Pneumocystis jirovecii pneumonia (PCP), especially those with HIV infection and low CD4 counts, the chest radiograph is often abnormal. It typically shows diffuse bilateral infiltrates, sometimes with a \"ground-glass\" appearance. However, a normal chest radiograph does not rule out PCP, as some patients may have normal X-rays early in the disease, or the radiograph may not show the typical features. Therefore, a normal chest radiograph should not exclude the diagnosis of PCP, especially if the clinical suspicion is high. Incorrect Options: (A) Most patients have CD4 counts <200 cells per µL at the time of diagnosis of their first episode of P. jiroveci pneumonia: This statement is true. Pneumocystis jirovecii pneumonia (PCP) is more common in HIV-infected individuals with CD4 counts below 200 cells per µL. This low CD4 count indicates severe immunosuppression, which predisposes patients to opportunistic infections such as PCP. As a result, a majority of patients will have CD4 counts under 200 at the time of their first PCP episode. (B) Most patients with P. jiroveci pneumonia will have an elevated serum lactate dehydrogenase level: This is also correct. Elevated serum lactate dehydrogenase (LDH) levels are commonly seen in patients with PCP, as LDH is released from damaged cells, including lung cells affected by the infection. Elevated LDH can be used as an indirect marker of tissue damage and inflammation in PCP. (C) Arterial blood gases in patients with P. jiroveci pneumonia frequently reveal respiratory alkalosis and a widened alveoloarterial oxygen tension difference: This statement is accurate. In PCP, arterial blood gases often show respiratory alkalosis due to tachypnea (rapid breathing) and hypoxemia. Additionally, there is usually a widened alveoloarterial oxygen tension gradient, indicating impaired gas exchange in the lungs due to the infection.",
      "correct_choice_id": 216716,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76169,
      "choices": [
        {
          "id": 216717,
          "text": "Staphylococcus aureus"
        },
        {
          "id": 216718,
          "text": "Streptococcus pyogenes"
        },
        {
          "id": 216719,
          "text": "Streptococcus pneumoniae"
        },
        {
          "id": 216720,
          "text": "Haemophilus influenzae"
        }
      ],
      "text": "The most common causative organism for lobar pneumonia is",
      "unique_key": "Q3291046",
      "question_audio": null,
      "question_video": null,
      "map_id": 34320211,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Streptococcus pneumoniae. Streptococcus pneumoniae is the most common causative organism of lobar pneumonia, particularly in otherwise healthy individuals. It typically causes a severe, localized infection that results in consolidation of one or more lobes of the lung, which is characteristic of lobar pneumonia. This bacterium is the leading cause of community-acquired pneumonia (CAP) and is known for its rapid onset and severity in patients with no underlying conditions, as well as in those with comorbidities. Incorrect Options: (A) Staphylococcus aureus: Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA), can cause pneumonia, but it is less commonly the cause of lobar pneumonia. It is more often associated with necrotizing pneumonia, abscesses, and complications, especially in hospitalized or immunocompromised individuals. While it can cause severe pneumonia, it is not as common as Streptococcus pneumoniae in causing lobar pneumonia. (B) Streptococcus pyogenes: Streptococcus pyogenes, the causative agent of group A streptococcal infections, can cause pneumonia, but it is more often associated with complications of upper respiratory tract infections, like pharyngitis, or with severe infections such as necrotizing fasciitis or toxic shock syndrome. It is a less common cause of lobar pneumonia compared to Streptococcus pneumoniae. (D) Haemophilus influenzae: Haemophilus influenzae is a common cause of pneumonia, particularly in individuals with underlying lung disease, such as COPD or in smokers. However, it is less frequently responsible for classic lobar pneumonia and is more often associated with bronchopneumonia or other forms of pneumonia with a more diffuse distribution. It does not commonly cause the localized, lobar pattern seen in typical pneumonia caused by Streptococcus pneumoniae.",
      "correct_choice_id": 216719,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76170,
      "choices": [
        {
          "id": 216721,
          "text": "OP treatment with Clarithromycin 500mg BID for one week"
        },
        {
          "id": 216722,
          "text": "Admit in ward and give Levofloxacin orally 750mg OD + Inj. Ceftriaxone 1G IV BID for one week"
        },
        {
          "id": 216723,
          "text": "Admit in ICCU and give Inj. Ceftriaxone 2G IV OD + IV levofloxacin 750mg OD for one week"
        },
        {
          "id": 216724,
          "text": "Piperacillin + tazobactam 4.5 G qid for one week"
        }
      ],
      "text": "A 30 year previously healthy male came with 2 days fever and cough with purulent sputum. Examination reveals an impaired note with bronchial breathing and crackles and increased vocal resonance. He is alert. BP=100/70. Respiratory rate =24/min. Blood urea=20 mg%. Which of the following is the best treatment for him?",
      "unique_key": "Q1831840",
      "question_audio": null,
      "question_video": null,
      "map_id": 34650324,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) OP treatment with Clarithromycin 500mg BID for one week. This patient presents with symptoms and signs suggestive of community-acquired pneumonia (CAP), including fever, cough with purulent sputum, impaired percussion note, bronchial breathing, crackles, and increased vocal resonance. His vitals are stable with a respiratory rate of 24/min, blood pressure of 100/70, and no altered mental status, indicating he has mild CAP that does not require hospital admission. The CURB-65 score for this patient is 0 (no confusion, urea 90 systolic or 60 diastolic, and age < 65 years), which supports outpatient management. Clarithromycin is a macrolide antibiotic effective against the typical and atypical pathogens responsible for CAP, such as Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, and Chlamydia pneumoniae. It is a first-line agent in treating mild CAP in otherwise healthy patients with no comorbidities or risk factors for drug-resistant organisms. Why Other Options Are Incorrect: (B) Admit in ward and give Levofloxacin orally 750mg OD + Inj. Ceftriaxone 1G IV BID for one week: This approach is overly aggressive for this patient. Hospital admission and the combination of levofloxacin (a respiratory fluoroquinolone) and ceftriaxone are typically reserved for patients with moderate to severe CAP or those with comorbidities, hemodynamic instability, or high CURB-65 scores. This patient’s vitals are stable, and there is no indication of severe disease, making ward admission unnecessary. (C) Admit in ICCU and give Inj. Ceftriaxone 2G IV OD + IV Levofloxacin 750mg OD for one week: This regimen is designed for critically ill patients, such as those with sepsis, respiratory failure, or shock due to severe CAP. The patient’s alertness, normal blood pressure, and lack of organ dysfunction exclude the need for ICU care. Administering high-dose ceftriaxone and levofloxacin in such a setting is excessive for a mild case like this. (D) Piperacillin + Tazobactam 4.5 G QID for one week: Piperacillin-tazobactam is a broad-spectrum antibiotic combination typically reserved for hospital-acquired pneumonia (HAP), healthcare-associated pneumonia (HCAP), or severe CAP in patients with risk factors for multidrug-resistant organisms. This patient does not have risk factors such as recent hospitalization, immunosuppression, or exposure to healthcare settings. Therefore, this regimen is inappropriate for outpatient treatment of mild CAP.",
      "correct_choice_id": 216721,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76171,
      "choices": [
        {
          "id": 216725,
          "text": "Presence of interstitial inflammation"
        },
        {
          "id": 216726,
          "text": "Predominance of alveolar exudates"
        },
        {
          "id": 216727,
          "text": "Bronchiolitis"
        },
        {
          "id": 216728,
          "text": "Multinucleate gaint cells in the bronchiolar wall"
        }
      ],
      "text": "All of following features are seen in the viral pneumonia except :",
      "unique_key": "Q3737830",
      "question_audio": null,
      "question_video": null,
      "map_id": 34721765,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Predominance of alveolar exudates. In viral pneumonia, the hallmark is inflammation of the interstitial tissues (interstitial pneumonia) rather than the alveoli. Viral infections primarily target the respiratory epithelium and the interstitium, leading to interstitial inflammation, which is characterized by mononuclear cell infiltrates and thickening of the alveolar walls. Alveolar exudates, predominantly seen in bacterial pneumonia, result from acute inflammatory responses involving neutrophils that fill the alveoli, which is not typical of viral pneumonia. Hence, predominance of alveolar exudates is not a feature of viral pneumonia. Why Other Options Are Correct: (A) Presence of interstitial inflammation: This is a classic feature of viral pneumonia. Viruses such as influenza, respiratory syncytial virus (RSV), and adenoviruses primarily infect the interstitial tissues, causing inflammation and edema. The alveoli themselves are generally spared from the significant accumulation of exudates seen in bacterial pneumonia. Interstitial thickening is a hallmark finding in viral pneumonia on imaging. (C) Bronchiolitis: Bronchiolitis is a common feature of viral pneumonia, especially in infections caused by RSV, influenza, and parainfluenza viruses. Viral infections cause inflammation and damage to the bronchioles, resulting in symptoms such as wheezing and dyspnea. This is particularly seen in children and young adults. (D) Multinucleate giant cells in the bronchiolar wall: Multinucleate giant cells are a histopathological feature seen in certain viral pneumonias, particularly those caused by paramyxoviruses like RSV and measles. The viral infection leads to the formation of syncytial cells (giant cells), which are a response to viral replication and fusion of infected epithelial cells.",
      "correct_choice_id": 216726,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76172,
      "choices": [
        {
          "id": 216729,
          "text": "Pseudomonas aeruginosa"
        },
        {
          "id": 216730,
          "text": "E.coli"
        },
        {
          "id": 216731,
          "text": "Klebsiella pneumonia"
        },
        {
          "id": 216732,
          "text": "Staphylococcus aureus"
        }
      ],
      "text": "50-year-old woman was admitted to the hospital with fever and cough. She has had no past medical problems and was well untilabout 3 days ago. Physical examination is remarkable for a temperature of 39_C and the presence of bronchial breath sounds on right side chest. Except for an elevated white count with a leftshifted differential, her blood tests are normal. Chest radiography reveals Right sided opacity.Which of the following organism can produce the below feature?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/course_file_meta/1160428q58medrespitry.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4637017",
      "question_audio": null,
      "question_video": null,
      "map_id": 34326096,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Klebsiella pneumoniae. Klebsiella pneumoniae is a common cause of community-acquired pneumonia (CAP), particularly in middle-aged or elderly patients with risk factors such as alcoholism, diabetes, or chronic illness, though it can also occur in previously healthy individuals. Klebsiella pneumonia typically produces a lobar consolidation visible as an opacity on chest radiographs, as seen in this patient. It is also associated with the production of thick, mucoid, \"currant jelly\" sputum, due to the organism's polysaccharide capsule. This encapsulation contributes to its virulence and the necrotizing nature of the infection, which can lead to abscess formation and cavitation in the lungs. The patient's high fever, bronchial breath sounds, and radiological findings of right-sided opacity are consistent with lobar pneumonia caused by Klebsiella pneumoniae. Why Other Options Are Incorrect: (A) Pseudomonas aeruginosa: Pseudomonas is a common cause of hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP) and is typically seen in patients with significant comorbidities such as cystic fibrosis, bronchiectasis, or immunosuppression. It often causes a more diffuse pattern on chest radiographs rather than a lobar opacity. Given this patient's previously healthy status and lack of exposure to healthcare settings, Pseudomonas is an unlikely cause. (B) Escherichia coli (E. coli): E. coli is an uncommon cause of community-acquired pneumonia. When it does occur, it is usually in the context of healthcare-associated infections or in severely immunocompromised patients. It often presents as bronchopneumonia rather than lobar pneumonia. This patient’s clinical and radiological features are not typical for E. coli as the causative organism. (D) Staphylococcus aureus: Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA), is a significant cause of post-viral pneumonia or hospital-acquired pneumonia, especially in patients with recent influenza infections or those with immunosuppression. It often causes bronchopneumonia with patchy infiltrates or cavitations rather than lobar consolidation. The absence of a recent viral illness or risk factors in this patient makes Staphylococcus aureus an unlikely cause.",
      "correct_choice_id": 216731,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76173,
      "choices": [
        {
          "id": 216733,
          "text": "Beta-lactams"
        },
        {
          "id": 216734,
          "text": "Macrolides"
        },
        {
          "id": 216735,
          "text": "Fluoroquinolones"
        },
        {
          "id": 216736,
          "text": "Tetracycline"
        }
      ],
      "text": "A 50 year old male was diagnosed with Mycoplasma pneumonia. The choice of a suitableantibiotic includes all of the following EXCEPT",
      "unique_key": "Q6030448",
      "question_audio": null,
      "question_video": null,
      "map_id": 34065719,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Beta-lactams. Mycoplasma pneumoniae is an atypical pathogen causing community-acquired pneumonia (CAP). It lacks a cell wall, making it inherently resistant to beta-lactam antibiotics (e.g., penicillins, cephalosporins, and carbapenems), which target bacterial cell wall synthesis. Since Mycoplasma does not possess a peptidoglycan layer, beta-lactams are ineffective against it, making them unsuitable for treatment. Instead, antibiotics that target protein synthesis or DNA replication are required. Why Other Options Are Correct: (B) Macrolides: Macrolides, such as azithromycin and clarithromycin, are highly effective against Mycoplasma pneumoniae. They inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit and are often the first-line treatment for Mycoplasma infections. Macrolides are particularly preferred in children and pregnant women due to their safety profile. (C) Fluoroquinolones: Fluoroquinolones, such as levofloxacin and moxifloxacin, are effective against Mycoplasma pneumoniae. They target bacterial DNA gyrase and topoisomerase IV, inhibiting DNA replication. Fluoroquinolones are commonly used in adults, particularly in cases of more severe infections or when macrolides cannot be used due to resistance or intolerance. (D) Tetracyclines: Tetracyclines, such as doxycycline, are effective against Mycoplasma pneumoniae by inhibiting protein synthesis through binding to the 30S ribosomal subunit. They are an alternative to macrolides, especially in adults. However, their use is limited in children under 8 years of age and pregnant women due to the risk of teeth discoloration and bone growth suppression.",
      "correct_choice_id": 216733,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76174,
      "choices": [
        {
          "id": 216737,
          "text": "Cotrimoxazole"
        },
        {
          "id": 216738,
          "text": "Pentamidine"
        },
        {
          "id": 216739,
          "text": "Dapsone"
        },
        {
          "id": 216740,
          "text": "Fluoroquinolones"
        }
      ],
      "text": "Drug that can be used in treatment in PCP pneumonia are all except:",
      "unique_key": "Q3592118",
      "question_audio": null,
      "question_video": null,
      "map_id": 34840512,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Fluoroquinolones. Pneumocystis jirovecii pneumonia (PCP) is a severe opportunistic infection seen in immunocompromised patients, particularly those with HIV/AIDS. The treatment of PCP focuses on drugs that specifically target the organism's metabolic pathways. Fluoroquinolones are not effective against Pneumocystis jirovecii, as this pathogen lacks the typical bacterial structures or enzymes (such as DNA gyrase or topoisomerase IV) that fluoroquinolones target. Hence, fluoroquinolones are not used in the treatment of PCP. Why Other Options Are Correct: (A) Cotrimoxazole: Cotrimoxazole (trimethoprim-sulfamethoxazole) is the first-line treatment for PCP. It works by inhibiting folate synthesis in Pneumocystis jirovecii, effectively disrupting its ability to reproduce. It is also used for prophylaxis in high-risk patients, such as those with low CD4 counts (<200 cells/μL) in HIV/AIDS. (B) Pentamidine: Pentamidine is an alternative to cotrimoxazole, used for the treatment of moderate to severe PCP or in patients who cannot tolerate cotrimoxazole. It can be administered intravenously for treatment or via inhalation for prophylaxis. Pentamidine interferes with the pathogen's RNA and DNA synthesis. (C) Dapsone: Dapsone, often used in combination with trimethoprim, is another alternative to cotrimoxazole for the treatment of PCP. It is effective in mild to moderate cases and is also used for prophylaxis. Dapsone works by inhibiting folate synthesis, similar to cotrimoxazole.",
      "correct_choice_id": 216740,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76175,
      "choices": [
        {
          "id": 216741,
          "text": "Streptococcus pneumoniae"
        },
        {
          "id": 216742,
          "text": "Haemophilus influenzae"
        },
        {
          "id": 216743,
          "text": "Legionella"
        },
        {
          "id": 216744,
          "text": "Anaerobes"
        }
      ],
      "text": "A 40-year-old alcoholic develops cough and fever. Chest x-ray shows an air-fluid level in the superior segment of the right lower lobe. The most likely etiologic agent is",
      "unique_key": "Q1715312",
      "question_audio": null,
      "question_video": null,
      "map_id": 34206910,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Anaerobes. This patient’s presentation, including cough, fever, and the presence of an air-fluid level on chest X-ray in the superior segment of the right lower lobe, is consistent with a lung abscess. Lung abscesses are commonly associated with aspiration, particularly in individuals with impaired consciousness, such as alcoholics. Anaerobic bacteria from the oral cavity (e.g., Peptostreptococcus, Fusobacterium, Prevotella, and Bacteroides species) are the most likely etiologic agents because they are introduced into the lower airways during aspiration. Alcoholics are at higher risk for aspiration due to depressed cough reflexes, altered mental status, and poor oral hygiene. Anaerobic infections typically lead to necrotizing pneumonia or abscess formation, often presenting with putrid sputum and constitutional symptoms like fever. Why Other Options Are Incorrect: (A) Streptococcus pneumoniae: Although Streptococcus pneumoniae is the most common cause of community-acquired pneumonia, it typically presents as lobar pneumonia without abscess or air-fluid levels on imaging. Lung abscesses caused by Streptococcus pneumoniae are rare and would usually occur in immunocompromised individuals or as a secondary complication. (B) Haemophilus influenzae: Haemophilus influenzae is associated with bronchopneumonia or exacerbations of chronic obstructive pulmonary disease (COPD). While it can cause pneumonia, it rarely leads to abscess formation or air-fluid levels. This organism is unlikely in an otherwise healthy adult without underlying pulmonary disease. (C) Legionella: Legionella pneumophila causes Legionnaires’ disease, a form of atypical pneumonia characterized by systemic symptoms such as confusion, diarrhea, and hyponatremia. It typically presents with patchy or lobar infiltrates on chest X-ray, not air-fluid levels or abscesses. Aspiration or anaerobic infection is a more likely cause in this clinical scenario.",
      "correct_choice_id": 216744,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76176,
      "choices": [
        {
          "id": 216745,
          "text": "Staph aureus"
        },
        {
          "id": 216746,
          "text": "Strept. pneumonia"
        },
        {
          "id": 216747,
          "text": "Klebsiella"
        },
        {
          "id": 216748,
          "text": "Pseudomonas"
        }
      ],
      "text": "Most commonorganism agent for early onset noscomial pneumonia",
      "unique_key": "Q5234055",
      "question_audio": null,
      "question_video": null,
      "map_id": 34872728,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Streptococcus pneumoniae. Early-onset nosocomial pneumonia refers to pneumonia that occurs within the first 4–5 days of hospital admission. In these cases, the causative organisms are often similar to those seen in community-acquired pneumonia (CAP). Streptococcus pneumoniae, a common cause of CAP, is the most likely etiologic agent in early-onset nosocomial pneumonia. This is because patients hospitalized for a short period are less likely to be colonized by multidrug-resistant (MDR) organisms, and the infection often arises from community-acquired pathogens already present in the respiratory tract. Why Other Options Are Incorrect: (A) Staphylococcus aureus: Staphylococcus aureus, particularly methicillin-resistant Staphylococcus aureus (MRSA), is a significant cause of late-onset nosocomial pneumonia (developing after 5 days of hospitalization). It is typically associated with patients who have been exposed to invasive devices (e.g., ventilators) or those who are immunocompromised. While it can occasionally cause early-onset pneumonia, it is not the most common organism in this scenario. (C) Klebsiella: Klebsiella pneumoniae is a Gram-negative bacterium more commonly associated with late-onset nosocomial pneumonia or in patients with risk factors such as diabetes, alcoholism, or prolonged hospital stays. It is also a common pathogen in ventilator-associated pneumonia (VAP). Early-onset pneumonia is less frequently caused by Klebsiella. (D) Pseudomonas aeruginosa: Pseudomonas aeruginosa is a key pathogen in late-onset nosocomial pneumonia, particularly in immunocompromised patients or those with structural lung diseases (e.g., bronchiectasis, cystic fibrosis). It is a highly resistant organism that colonizes hospitalized patients over time. It is not typically implicated in early-onset nosocomial pneumonia.",
      "correct_choice_id": 216746,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76177,
      "choices": [
        {
          "id": 216749,
          "text": "H. Influenza"
        },
        {
          "id": 216750,
          "text": "Pneumococcus"
        },
        {
          "id": 216751,
          "text": "Legionella"
        },
        {
          "id": 216752,
          "text": "P. aeruginosa"
        }
      ],
      "text": "In patients with severe structural lung disease, such as bronchiectasis the infective agent most likely to cause pneumonia is",
      "unique_key": "Q7243257",
      "question_audio": null,
      "question_video": null,
      "map_id": 34926897,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) P. aeruginosa. In patients with severe structural lung disease like bronchiectasis, Pseudomonas aeruginosa is the most likely causative pathogen for pneumonia. This is because P. aeruginosa is a common pathogen in individuals with chronic lung conditions due to its ability to colonize the airways and form biofilms, making it difficult to eradicate. It is more prevalent in patients with bronchiectasis, cystic fibrosis, or chronic obstructive pulmonary disease (COPD), where the structural damage to the airways increases the risk of recurrent infections. The pathogen can cause severe, chronic infections and is known for its antibiotic resistance mechanisms, which make it challenging to treat. Why Other Options Are Incorrect: (A) H. Influenza: Haemophilus influenzae is a common cause of respiratory tract infections in individuals with bronchiectasis and can contribute to pneumonia in such patients. However, while it is a frequent pathogen in bronchiectasis, it is less likely to cause the severe infections seen in the setting of advanced bronchiectasis compared to Pseudomonas aeruginosa, which is known to be more virulent in these patients. Thus, H. Influenza is not the most likely cause of severe pneumonia in this group. (B) Pneumococcus: Streptococcus pneumoniae (pneumococcus) is a common cause of community-acquired pneumonia and can cause pneumonia in patients with bronchiectasis. However, P. aeruginosa tends to be more prevalent and problematic in patients with severe structural lung diseases like bronchiectasis. Pneumococcus is more associated with acute infections and is generally seen in patients without significant chronic lung disease or in those with milder forms of lung disease. (C) Legionella: Legionella pneumophila is a less common cause of pneumonia, typically associated with contaminated water sources, such as air-conditioning units and water systems. While Legionella infections can cause severe pneumonia, it is not the most common pathogen in patients with bronchiectasis, and it is more often associated with outbreaks or specific environmental exposures rather than being the primary pathogen in chronic lung conditions like bronchiectasis.",
      "correct_choice_id": 216752,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76178,
      "choices": [
        {
          "id": 216753,
          "text": "Pulmonary infiltrate"
        },
        {
          "id": 216754,
          "text": "Distal bronchiectasis"
        },
        {
          "id": 216755,
          "text": "Bronchial asthma"
        },
        {
          "id": 216756,
          "text": "Peripheral eosinophilia"
        }
      ],
      "text": "The following are main diagnostic criteria for Allergic Bronchopulmonary Aspergillosis EXCEPT",
      "unique_key": "Q9714955",
      "question_audio": null,
      "question_video": null,
      "map_id": 34646981,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Distal bronchiectasis. In Allergic Bronchopulmonary Aspergillosis (ABPA), the key diagnostic criteria include clinical, radiological, and laboratory findings that reflect a hypersensitivity response to the fungus Aspergillus. Distal bronchiectasis is not a primary diagnostic feature of ABPA. Instead, proximal bronchiectasis, particularly in the central airways, is more commonly observed. Although bronchiectasis can occur in ABPA, it is not limited to the distal regions of the lungs and is not considered a defining diagnostic feature of the condition. Why the other options are correct: A. Pulmonary infiltrate: Pulmonary infiltrates, often in the form of eosinophilic pneumonia or fleeting opacities, are common in ABPA. These infiltrates are part of the inflammatory response to Aspergillus colonization and hypersensitivity, making them a central diagnostic feature. C. Bronchial asthma: Asthma is a key component of ABPA. Most patients with ABPA have pre-existing asthma, and exacerbations of asthma are often seen during fungal sensitization. The presence of asthma along with other findings strongly suggests ABPA. D. Peripheral eosinophilia: Peripheral eosinophilia is one of the hallmark findings in ABPA. This elevated eosinophil count in the blood is reflective of the immune response to the Aspergillus antigen and is commonly seen in patients with ABPA, aiding in its diagnosis.",
      "correct_choice_id": 216754,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76179,
      "choices": [
        {
          "id": 216757,
          "text": "Isocyanates"
        },
        {
          "id": 216758,
          "text": "Mycobacterium avium complex"
        },
        {
          "id": 216759,
          "text": "Molds in air conditioners"
        },
        {
          "id": 216760,
          "text": "Legionella"
        }
      ],
      "text": "Hot tub lung is related to",
      "unique_key": "Q5725613",
      "question_audio": null,
      "question_video": null,
      "map_id": 34907624,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Mycobacterium avium complex. Hot tub lung is a type of hypersensitivity pneumonitis that occurs due to inhalation of contaminated water droplets from hot tubs, spas, or whirlpools. The bacterium Mycobacterium avium complex (MAC) is the most common causative organism. This bacterium is found in warm, moist environments like hot tubs, and when inhaled, it can lead to inflammation of the lung tissue, manifesting as hot tub lung. It typically presents with symptoms such as cough, shortness of breath, fever, and fatigue, and is associated with granulomatous inflammation. Why the other options are incorrect: A. Isocyanates: Isocyanates are chemicals that can cause occupational asthma and hypersensitivity pneumonitis, but they are not linked to hot tub lung. Isocyanates are commonly found in industries like painting, foaming, and manufacturing, not in hot tubs. C. Molds in air conditioners: Molds can cause hypersensitivity pneumonitis when inhaled, but they are typically associated with environments where mold growth is prominent, such as in air conditioning systems or poorly ventilated spaces. However, molds in air conditioners are not the primary cause of hot tub lung. D. Legionella: Legionella is a type of bacteria that causes Legionnaires' disease, a form of pneumonia typically linked to contaminated water sources like cooling towers or air conditioning systems. While Legionella can cause respiratory infections, it is not the causative organism of hot tub lung.",
      "correct_choice_id": 216758,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76180,
      "choices": [
        {
          "id": 216761,
          "text": "Thermophilus actinomycetes"
        },
        {
          "id": 216762,
          "text": "Aspergillus"
        },
        {
          "id": 216763,
          "text": "Penicillium glabrum"
        },
        {
          "id": 216764,
          "text": "Rhizopus"
        }
      ],
      "text": "Causative agent of farmer‘s lung is:",
      "unique_key": "Q2117820",
      "question_audio": null,
      "question_video": null,
      "map_id": 34299750,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Thermophilus actinomycetes. Farmer’s lung is a type of hypersensitivity pneumonitis caused by the inhalation of organic dust, which often contains actinomycetes, a group of bacteria. Specifically, Thermophilus actinomycetes is a key causative agent of this condition. These bacteria are commonly found in moldy hay, straw, or silage—common materials that farmers or agricultural workers may be exposed to. The inhalation of these dust particles can trigger an immune response in the lungs, leading to inflammation, coughing, shortness of breath, and other symptoms of farmer's lung. Why the other options are incorrect: B. Aspergillus: Aspergillus is a genus of molds that can cause various types of lung disease, such as aspergillosis. While Aspergillus species can contribute to allergic bronchopulmonary aspergillosis (ABPA) or fungal infections, it is not the primary causative agent of farmer's lung, which is mainly associated with actinomycetes. C. Penicillium glabrum: Penicillium glabrum is another species of mold, but it is not typically associated with farmer’s lung. While Penicillium species can contribute to respiratory issues, they are not the main cause of the hypersensitivity pneumonitis seen in agricultural workers. Thermophilus actinomycetes are far more commonly implicated in this condition. D. Rhizopus: Rhizopus is a mold genus that can cause infections, especially in immunocompromised individuals, leading to conditions like mucormycosis. However, it is not the causative agent of farmer’s lung. The condition is most commonly linked to exposure to thermophilic actinomycetes found in organic dust on farms, not Rhizopus.",
      "correct_choice_id": 216761,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76181,
      "choices": [
        {
          "id": 216765,
          "text": "Pulmonary TB"
        },
        {
          "id": 216766,
          "text": "Sarcoidosis"
        },
        {
          "id": 216767,
          "text": "Histoplasmosis"
        },
        {
          "id": 216768,
          "text": "All"
        }
      ],
      "text": "Endobronchial saprophytic pulmonary aspergillosis presents in a patient with prior",
      "unique_key": "Q8103015",
      "question_audio": null,
      "question_video": null,
      "map_id": 34549925,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All. Endobronchial saprophytic pulmonary aspergillosis is a condition where Aspergillus species, typically Aspergillus fumigatus, colonize the bronchial tree, forming a saprophytic growth. This condition is more common in individuals with a history of lung diseases that cause chronic lung damage or alterations in lung architecture. The underlying diseases like pulmonary tuberculosis (TB), sarcoidosis, and histoplasmosis can predispose patients to this condition by causing fibrosis, cavities, or altered immune responses in the lungs, creating an environment where Aspergillus can grow. Why the other options are correct: A. Pulmonary TB: Pulmonary tuberculosis (TB) can lead to lung cavities, which provide an ideal environment for the growth of Aspergillus species. Patients with chronic pulmonary TB often have structural lung damage, such as cavities or fibrosis, which can facilitate the development of endobronchial saprophytic pulmonary aspergillosis. B. Sarcoidosis: Sarcoidosis is an inflammatory condition that can lead to lung fibrosis and scarring, creating a favorable environment for the growth of Aspergillus. It is also associated with granulomas, which can sometimes house fungal organisms, including Aspergillus. Therefore, sarcoidosis is another predisposing factor for endobronchial saprophytic pulmonary aspergillosis. C. Histoplasmosis: Histoplasmosis, caused by the fungus Histoplasma capsulatum, can result in lung lesions, granulomas, and fibrosis. These lung abnormalities can predispose individuals to develop endobronchial saprophytic pulmonary aspergillosis. The chronic damage caused by histoplasmosis provides an opportunity for Aspergillus colonization in the airways.",
      "correct_choice_id": 216768,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76182,
      "choices": [
        {
          "id": 216769,
          "text": "acute respiratory failure thatoften requires mechanical ventilation"
        },
        {
          "id": 216770,
          "text": "diffuse pulmonary infiltrates,"
        },
        {
          "id": 216771,
          "text": "Bronchoalveolar lavage eosinophilia >25%"
        },
        {
          "id": 216772,
          "text": "Poor clinical response to corticosteroids"
        }
      ],
      "text": "Regarding Acute eosinophilic pneumonia true except",
      "unique_key": "Q9988931",
      "question_audio": null,
      "question_video": null,
      "map_id": 34730192,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Poor clinical response to corticosteroids. Acute eosinophilic pneumonia (AEP) is a rare, rapidly progressive disorder characterized by an eosinophilic infiltrate in the lungs. It typically presents with acute respiratory failure and can progress rapidly, requiring mechanical ventilation in some cases. The key to its treatment is corticosteroids, which usually result in a significant clinical improvement. AEP responds well to corticosteroid therapy, and this is why the statement that AEP has a \"poor clinical response to corticosteroids\" is incorrect. Why the other options are correct: A. Acute respiratory failure that often requires mechanical ventilation: Acute eosinophilic pneumonia often presents with severe respiratory distress, which can progress to acute respiratory failure. This is due to diffuse pulmonary infiltrates and hypoxemia. In severe cases, mechanical ventilation may be required to support the patient while they are being treated. B. Diffuse pulmonary infiltrates: Diffuse pulmonary infiltrates are a hallmark of acute eosinophilic pneumonia. These infiltrates are typically visible on chest radiography and CT scans, and they correspond to the accumulation of eosinophils and other inflammatory cells in the lungs. The infiltrates contribute to the acute respiratory symptoms seen in this condition. C. Bronchoalveolar lavage eosinophilia >25%: In acute eosinophilic pneumonia, bronchoalveolar lavage (BAL) is often performed to help diagnose the condition. The eosinophil count in BAL fluid is typically greater than 25%, which helps confirm the diagnosis. This is one of the diagnostic criteria for AEP, as the presence of eosinophils in the airways and alveoli is central to the pathophysiology of the disease.",
      "correct_choice_id": 216772,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76183,
      "choices": [
        {
          "id": 216773,
          "text": "Most patients are female nonsmokers with a mean age of 45"
        },
        {
          "id": 216774,
          "text": "Negative photographic pulmonary edema” appearance on chest x-ray and chest CT is pathognomonic"
        },
        {
          "id": 216775,
          "text": "mean BALeosinophil counts of ~60%."
        },
        {
          "id": 216776,
          "text": "Lung biopsy is often required to establish adiagnosis"
        }
      ],
      "text": "Regarding Chronic eosinophilic pneumonia true except",
      "unique_key": "Q1821057",
      "question_audio": null,
      "question_video": null,
      "map_id": 34852736,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Lung biopsy is often required to establish a diagnosis. Chronic eosinophilic pneumonia (CEP) is a condition characterized by chronic eosinophilic infiltration in the lungs. Unlike other pulmonary conditions, a lung biopsy is rarely required to establish the diagnosis of CEP. The diagnosis is usually made based on clinical symptoms, radiographic findings, and bronchoalveolar lavage (BAL) results. In many cases, the diagnosis can be confirmed with non-invasive tests, such as imaging studies and BAL fluid analysis, which show a high percentage of eosinophils. Therefore, a lung biopsy is typically not needed to diagnose chronic eosinophilic pneumonia, making option D the false statement. Why the other options are correct: A. Most patients are female nonsmokers with a mean age of 45: Chronic eosinophilic pneumonia typically affects middle-aged females, and the majority of patients are nonsmokers. The mean age of diagnosis is around 45 years, which is consistent with the characteristic patient profile for this condition. B. Negative photographic pulmonary edema appearance on chest x-ray and chest CT is pathognomonic: Chest X-ray and CT findings in chronic eosinophilic pneumonia often show infiltrates that may have a \"photographic pulmonary edema\" appearance, which refers to the pattern of consolidation or \"ground-glass opacities\" in a peripheral and basal distribution. This appearance is indeed a pathognomonic feature for chronic eosinophilic pneumonia. C. Mean BAL eosinophil counts of ~60%: Bronchoalveolar lavage (BAL) is a key diagnostic tool in chronic eosinophilic pneumonia. A mean eosinophil count of approximately 60% in BAL fluid is commonly seen in patients with CEP. The high proportion of eosinophils in the lavage fluid supports the diagnosis of chronic eosinophilic pneumonia, reflecting the inflammatory response in the lungs.",
      "correct_choice_id": 216776,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76184,
      "choices": [
        {
          "id": 216777,
          "text": "Symptoms 4-8 hours after exposure"
        },
        {
          "id": 216778,
          "text": "Recurrent episodes of symptoms"
        },
        {
          "id": 216779,
          "text": "Positive precipitins"
        },
        {
          "id": 216780,
          "text": "Exposure to a known offending antigen"
        }
      ],
      "text": "What is the strongest predictor of the diagnosis of HP?",
      "unique_key": "Q7298264",
      "question_audio": null,
      "question_video": null,
      "map_id": 34523136,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Exposure to a known offending antigen. Hypersensitivity pneumonitis (HP) is an inflammatory response in the lungs caused by inhalation of organic dust, fungi, or other environmental antigens. The strongest predictor of HP is exposure to a known offending antigen, which can be a specific mold, bird droppings, or other particles that trigger the immune response. Identifying a direct link between the patient's symptoms and exposure to a specific antigen is essential for confirming the diagnosis. Therefore, the strongest predictor is knowing the patient has had contact with an antigen known to cause hypersensitivity pneumonitis. Why the other options are incorrect: A. Symptoms 4-8 hours after exposure: While symptoms often occur 4-8 hours after exposure to the offending antigen in acute hypersensitivity pneumonitis, this is not the strongest predictor of the diagnosis. Symptoms may vary and may also occur hours or days after exposure, and this timing alone is insufficient to confirm the diagnosis. Knowing the specific antigen causing the reaction is much more definitive. B. Recurrent episodes of symptoms: Recurrent episodes of symptoms are characteristic of chronic hypersensitivity pneumonitis, where repeated exposures lead to ongoing inflammation. However, while recurrent symptoms may be a clue to the diagnosis, they do not provide a stronger predictive value than identifying a specific offending antigen, which is a more direct link to the condition. C. Positive precipitins: Positive precipitins indicate the presence of specific antibodies to antigens related to hypersensitivity pneumonitis. However, having positive precipitins alone is not enough to confirm the diagnosis, as they can be present in other conditions or in individuals with no symptoms. Therefore, the presence of precipitating antibodies is important, but exposure to the known offending antigen is a stronger predictor.",
      "correct_choice_id": 216780,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76185,
      "choices": [
        {
          "id": 216781,
          "text": "Stage 0 sarcoidosis"
        },
        {
          "id": 216782,
          "text": "Stage 1 sarcoidosis"
        },
        {
          "id": 216783,
          "text": "Stage 2 sarcoidosis"
        },
        {
          "id": 216784,
          "text": "Stage 3 sarcoidosis"
        }
      ],
      "text": "A 20 years old women presents with a dry cough and dyspnoea. A Chest X-ray has beenperformed and demonstrates bilateral hilar lymphadenopathy with bilateral well defined 3mmparenchymal nodules. The diagnosis is most likely to be?",
      "unique_key": "Q1429700",
      "question_audio": null,
      "question_video": null,
      "map_id": 34089454,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Stage 2 sarcoidosis. Stage 2 sarcoidosis is characterized by bilateral hilar lymphadenopathy (enlarged lymph nodes in the chest) along with bilateral pulmonary parenchymal nodules on imaging. The patient's symptoms of dry cough and dyspnea combined with the chest X-ray findings of hilar lymphadenopathy and well-defined 3mm nodules are consistent with this stage of the disease. Sarcoidosis is a granulomatous disorder that often affects young adults, and the chest X-ray findings are crucial in staging the disease. Stage 2 typically includes lymphadenopathy and lung parenchymal involvement. Why the other options are incorrect: A. Stage 0 sarcoidosis: Stage 0 sarcoidosis refers to a condition where there are no chest X-ray abnormalities present, meaning no visible lung or lymph node involvement. The presence of bilateral hilar lymphadenopathy and pulmonary nodules on the chest X-ray eliminates this as a possibility for this patient. B. Stage 1 sarcoidosis: Stage 1 sarcoidosis is characterized by isolated bilateral hilar lymphadenopathy, without any pulmonary parenchymal involvement (no nodules). While this patient does have hilar lymphadenopathy, she also has pulmonary nodules, which would place her diagnosis at Stage 2 rather than Stage 1. D. Stage 3 sarcoidosis: Stage 3 sarcoidosis is marked by pulmonary parenchymal fibrosis and significant lung involvement, which often presents with reticulonodular infiltrates or fibrotic changes seen on imaging. This patient's chest X-ray does not show the typical findings of fibrosis or advanced pulmonary changes that are characteristic of Stage 3. Additionally, the patient's symptoms (dry cough and dyspnea) are more consistent with an earlier stage of the disease rather than the fibrosis seen in Stage 3.",
      "correct_choice_id": 216783,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76186,
      "choices": [
        {
          "id": 216785,
          "text": "Cryptogenic Organizing Pneumonia"
        },
        {
          "id": 216786,
          "text": "Non specificinterstitialpneumona"
        },
        {
          "id": 216787,
          "text": "Usual interstitial pneumonia."
        },
        {
          "id": 216788,
          "text": "Desquamativeinterstitial pneumonia."
        }
      ],
      "text": "A Female presents with history of progressive breathlessness. Histology shows heterogenouspatchy fibrosis with several fibroblastic foci. The most likely diagnosis?",
      "unique_key": "Q3515049",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578259,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Usual interstitial pneumonia (UIP). Usual interstitial pneumonia (UIP) is characterized by a heterogeneous pattern of patchy fibrosis with fibroblastic foci on histology. These fibroblastic foci are indicative of areas of active fibrosis. UIP is the histopathologic pattern seen in idiopathic pulmonary fibrosis (IPF), which often presents with progressive breathlessness. The histologic features of UIP include patchy fibrosis, honeycombing, and areas of normal lung tissue interspersed with fibrotic tissue, which is consistent with the description provided in this case. The fibroblastic foci (areas where fibroblasts proliferate) suggest ongoing fibrosis, a hallmark of UIP. Why the other options are incorrect: A. Cryptogenic Organizing Pneumonia (COP): Cryptogenic organizing pneumonia (COP), previously known as bronchiolitis obliterans organizing pneumonia (BOOP), is characterized by fibrosis in the small airways and alveolar spaces, leading to the formation of polypoid plugs of granulation tissue. This condition is usually more homogeneous compared to the patchy and heterogeneous fibrosis seen in UIP. COP typically presents with a cough and dyspnea rather than the progressive breathlessness seen in UIP, and it lacks the characteristic fibroblastic foci found in UIP. B. Non-specific interstitial pneumonia (NSIP): Non-specific interstitial pneumonia (NSIP) presents with uniform fibrosis and inflammation without the marked architectural distortion seen in UIP. On histology, NSIP shows mild to moderate fibrosis without the fibroblastic foci or honeycombing seen in UIP. The fibrosis in NSIP is typically more homogeneous than the patchy and heterogeneous fibrosis found in UIP, making it less likely in this case. The progressive breathlessness and patchy fibrosis with fibroblastic foci point more toward UIP. D. Desquamative interstitial pneumonia (DIP): Desquamative interstitial pneumonia (DIP) is a form of interstitial lung disease typically associated with smoking and is characterized by alveolar macrophage accumulation in the airspaces. On histology, DIP shows marked alveolar inflammation and macrophage infiltration with minimal fibrosis, unlike the patchy fibrosis seen in UIP. It is also not associated with the prominent fibroblastic foci that characterize UIP. Additionally, the pattern of fibrosis described in the case is not typical for DIP.",
      "correct_choice_id": 216787,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76187,
      "choices": [
        {
          "id": 216789,
          "text": "Cavity commonly seen"
        },
        {
          "id": 216790,
          "text": "Spontaneous remission is usual"
        },
        {
          "id": 216791,
          "text": "Tuberculin test is negative"
        },
        {
          "id": 216792,
          "text": "Bilateral hilar lymphadenopathy"
        }
      ],
      "text": "All are correct regarding sarcoidosis except",
      "unique_key": "Q8399165",
      "question_audio": null,
      "question_video": null,
      "map_id": 34765541,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Cavity commonly seen. Sarcoidosis is an inflammatory disease that often presents with noncaseating granulomas and is most commonly found in the lungs and lymph nodes. One of its hallmark features is bilateral hilar lymphadenopathy on chest imaging, and it does not typically lead to the formation of cavities in the lungs. Cavitary lesions are more characteristic of tuberculosis or other infectious diseases but are not commonly seen in sarcoidosis. Therefore, statement A is incorrect. Why the other options are correct: B. Spontaneous remission is usual: Sarcoidosis often shows spontaneous remission, especially in mild cases. Many patients experience an initial worsening of symptoms, followed by gradual improvement without treatment, especially in early-stage sarcoidosis. In some cases, it resolves completely without requiring significant intervention. C. Tuberculin test is negative: Sarcoidosis is characterized by negative tuberculin skin tests (also known as the TST or PPD test). Unlike tuberculosis, sarcoidosis is not caused by Mycobacterium tuberculosis, and patients with sarcoidosis typically do not react to the tuberculin test, which is used to test for exposure to tuberculosis. D. Bilateral hilar lymphadenopathy: Bilateral hilar lymphadenopathy is a classic finding in sarcoidosis. It is commonly observed in chest X-rays and is a key radiographic feature of the disease. The presence of enlarged lymph nodes in the chest is often a distinguishing factor of sarcoidosis and is present in up to 90% of patients with the disease.",
      "correct_choice_id": 216789,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76188,
      "choices": [
        {
          "id": 216793,
          "text": "Pirfenidone"
        },
        {
          "id": 216794,
          "text": "Bosentan"
        },
        {
          "id": 216795,
          "text": "Acetylcysteine"
        },
        {
          "id": 216796,
          "text": "Prednisolone/azathioprine"
        }
      ],
      "text": "A 75/M is referred for dyspnoea on exertion and chronic cough that have worsened progressively over the past12 months. PFT shows restriction with DLCO of 38% predicted. The chest radiograph shows bilateral patchyinfltrates, mostly at the lung bases. On HRCT, bilateral reticular opacities and clustered basal honeycombing arefound. Open-lung biopsy reveals randomly distributed fibrotic foci surrounded by normal lung parenchyma. What isthe most appropriate therapy for this patient?",
      "unique_key": "Q9406403",
      "question_audio": null,
      "question_video": null,
      "map_id": 34334515,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Pirfenidone. This patient's presentation is consistent with Idiopathic Pulmonary Fibrosis (IPF), which is a type of interstitial lung disease (ILD). The clinical symptoms of dyspnea on exertion and chronic cough, along with the radiographic findings of bilateral patchy infiltrates, reticular opacities, and honeycombing on HRCT, strongly suggest IPF. The fibrotic foci surrounded by normal lung parenchyma seen on biopsy is a typical finding in IPF. The most appropriate therapy for IPF includes anti-fibrotic drugs, and pirfenidone is one of the FDA-approved agents for treating IPF. Pirfenidone is known to slow disease progression by inhibiting fibrosis and inflammation in the lungs. It has been shown in clinical studies to reduce the decline in lung function and improve survival in patients with IPF. Why the other options are incorrect: B. Bosentan: Bosentan is an endothelin receptor antagonist used primarily for the treatment of pulmonary arterial hypertension (PAH). Although PAH can occur in association with interstitial lung disease, it is not the first-line therapy for IPF. Bosentan would not be effective in treating the underlying fibrosis or improving the respiratory symptoms in IPF. C. Acetylcysteine: Acetylcysteine is an antioxidant and mucolytic agent. It has been studied in ILD, particularly in chronic obstructive pulmonary disease (COPD) and bronchiectasis, but it does not have proven benefit in IPF. There is no strong evidence supporting its use in the treatment of IPF to improve outcomes or reduce fibrosis. D. Prednisolone/azathioprine: Prednisolone and azathioprine are immunosuppressive agents that may be used in certain inflammatory interstitial lung diseases, such as non-specific interstitial pneumonia (NSIP) or acute exacerbations of IPF. However, they are not effective for IPF and may even worsen outcomes in some patients with IPF. Immunosuppressive therapy is generally not recommended as first-line treatment for IPF due to potential harm and lack of benefit.",
      "correct_choice_id": 216793,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76189,
      "choices": [
        {
          "id": 216797,
          "text": "Sarcoidosis"
        },
        {
          "id": 216798,
          "text": "TB"
        },
        {
          "id": 216799,
          "text": "Lymphoma"
        },
        {
          "id": 216800,
          "text": "Silicosis"
        }
      ],
      "text": "A 25 Yr old male with fever, cough and expectoration, SOB 2 months duration. CECT chest showing B/L upper lobe fibrotic lesions, mediastinal necrotic Lymphnodes with peripheral rim enhancement. Diagnosis can be :",
      "unique_key": "Q3387762",
      "question_audio": null,
      "question_video": null,
      "map_id": 34962087,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Tuberculosis (TB). The patient's clinical presentation and CECT chest findings are most consistent with tuberculosis: Clinical presentation: The patient is presenting with fever, cough, expectoration, and shortness of breath for 2 months. These are classic symptoms of pulmonary tuberculosis (TB). TB can cause chronic cough, fever, weight loss, and night sweats, which are all consistent with this presentation. CECT chest findings: The bilateral upper lobe fibrotic lesions and mediastinal necrotic lymph nodes with peripheral rim enhancement are strongly suggestive of tuberculosis. The upper lobe involvement is typical of TB as the bacteria preferentially affect the upper lobes due to the higher oxygen content. Mediastinal lymphadenopathy with necrosis and rim enhancement is often seen in active TB and is a characteristic feature in adult pulmonary tuberculosis. Chronicity and systemic symptoms: The patient's symptoms have been persistent for 2 months, which is common for TB, which typically presents with a prolonged course. Why the other options are incorrect: A. Sarcoidosis: While sarcoidosis can present with mediastinal lymphadenopathy and upper lobe lesions, it typically does not cause necrotic lymph nodes with peripheral rim enhancement, which is more characteristic of infections such as TB. Sarcoidosis usually presents with non-caseating granulomas and often has a more insidious onset without the systemic infection symptoms like fever and expectoration seen in TB. C. Lymphoma: Lymphoma can cause mediastinal lymphadenopathy, but it does not typically present with upper lobe fibrotic lesions or necrotic lymph nodes with the typical peripheral rim enhancement seen in TB. Lymphoma usually presents with painless swelling of lymph nodes and does not cause the same chronic cough, expectoration, and fever as seen in TB. D. Silicosis: Silicosis is a form of pneumoconiosis caused by inhalation of silica dust and usually presents with lung fibrosis, particularly in workers exposed to silica dust. However, it does not typically cause necrotic lymph nodes or the upper lobe involvement with the characteristic imaging features seen in this patient. Silicosis typically has a more insidious onset and is not associated with systemic infection symptoms such as fever and cough.",
      "correct_choice_id": 216798,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76190,
      "choices": [
        {
          "id": 216801,
          "text": "Antigens from all BCG strains and nontuberculous mycobacteria are present in the assay"
        },
        {
          "id": 216802,
          "text": "Specificity of the test is superior to Tuberculin skin test in BCG vaccinated patients"
        },
        {
          "id": 216803,
          "text": "Sensitivity is comparable to Tuberculin skin test"
        },
        {
          "id": 216804,
          "text": "Sensitivity is reduced in HIV infection with low CD4 count"
        }
      ],
      "text": "The following are true regarding Interferon Gamma release assays in tuberculosis EXCEPT",
      "unique_key": "Q2252634",
      "question_audio": null,
      "question_video": null,
      "map_id": 34761666,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Antigens from all BCG strains and nontuberculous mycobacteria are present in the assay. Interferon Gamma Release Assays (IGRAs), such as the QuantiFERON test, do not use antigens from all BCG strains and nontuberculous mycobacteria. Instead, they use specific tuberculosis-specific antigens (like ESAT-6 and CFP-10) that are present in Mycobacterium tuberculosis but are not found in BCG or most nontuberculous mycobacteria. This makes IGRAs more specific for Mycobacterium tuberculosis infection compared to the Tuberculin Skin Test (TST), which may cross-react with antigens from BCG or nontuberculous mycobacteria. Why the other options are correct: B. Specificity of the test is superior to Tuberculin skin test in BCG vaccinated patients: This statement is true. IGRAs are more specific than the Tuberculin Skin Test (TST) in BCG-vaccinated individuals. Since the TST may react to BCG-derived antigens, it may give a false-positive result in BCG-vaccinated individuals. On the other hand, IGRAs are based on antigens that are not present in the BCG vaccine, thereby reducing the likelihood of false positives in those who have received BCG vaccination. C. Sensitivity is comparable to Tuberculin skin test: This statement is true. IGRAs and the TST have comparable sensitivities when it comes to detecting latent tuberculosis infection (LTBI). However, neither test is perfect, and sensitivity can be reduced in individuals with weakened immune systems, such as those with HIV or very young children. D. Sensitivity is reduced in HIV infection with low CD4 count: This statement is true. IGRAs may show reduced sensitivity in individuals with HIV, particularly when the CD4 count is very low. This is because the ability to mount a strong immune response (including gamma interferon production) may be compromised in those with immunocompromised conditions such as advanced HIV/AIDS. Therefore, IGRAs may not be as effective in detecting latent tuberculosis infection in these patients.",
      "correct_choice_id": 216801,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76191,
      "choices": [
        {
          "id": 216805,
          "text": "Perform an inteferon-γ release assay (IGRA)"
        },
        {
          "id": 216806,
          "text": "No further action is necessary at this time"
        },
        {
          "id": 216807,
          "text": "Repeat the skin test if CD4 cells fall below 200/uLd"
        },
        {
          "id": 216808,
          "text": "Prophylactic therapy with isoniazid for 6 months"
        }
      ],
      "text": "A 45-year-old HIV-positive male (CD4 cells 250 per uL), is referred to you because of atuberculin skin test with 7-mm induration. He has no specifc complaints, has not had contact with tuberculosis patients in the past. Chest radiography is normal. Which one of the following is the most appropriate next step?",
      "unique_key": "Q6007614",
      "question_audio": null,
      "question_video": null,
      "map_id": 34769886,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Prophylactic therapy with isoniazid for 6 months. This patient, who is HIV-positive with a CD4 count of 250/uL, has a 7-mm induration on the tuberculin skin test (TST), which is considered a positive result in an HIV-infected individual. The threshold for a positive TST in someone with HIV is 5 mm, meaning that any induration of 5 mm or more is suggestive of latent tuberculosis infection (LTBI), even if the patient is asymptomatic and has no known contact with tuberculosis (TB) patients. Since his chest radiograph is normal and there is no indication of active TB, the most appropriate next step is to initiate prophylactic therapy with isoniazid for 6 months to reduce the risk of developing active TB in the future. Why the other options are incorrect: A. Perform an interferon-γ release assay (IGRA): While IGRAs (such as the QuantiFERON-TB test) can also be used to diagnose latent TB infection, performing this test is not the most appropriate next step in this case. The TST result is already positive, and given the patient's HIV status and 7-mm induration, prophylactic therapy with isoniazid is the next appropriate step, regardless of the IGRA result. B. No further action is necessary at this time: This is incorrect. A 7-mm TST induration in an HIV-positive patient, even without specific complaints or known contact with TB patients, suggests latent tuberculosis infection. This is a high-risk group for progressing to active TB, so prophylactic therapy with isoniazid is necessary to prevent this progression. C. Repeat the skin test if CD4 cells fall below 200/uL: This is incorrect. The patient's TST result is already positive with a 7-mm induration, which warrants intervention. Repeating the skin test is not necessary, and delaying treatment until the CD4 count falls below 200/uL would not be appropriate. Immediate prophylactic therapy with isoniazid is the recommended course of action to prevent the development of active TB in the future.",
      "correct_choice_id": 216808,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76192,
      "choices": [
        {
          "id": 216809,
          "text": "It has a chronic course"
        },
        {
          "id": 216810,
          "text": "It causes mild intermittent fever and anemia"
        },
        {
          "id": 216811,
          "text": "Meningeal involvement precedes death"
        },
        {
          "id": 216812,
          "text": "It is commonly seen in children"
        }
      ],
      "text": "Regarding cryptic miliary tuberculosis all are correct EXCEPT",
      "unique_key": "Q6312919",
      "question_audio": null,
      "question_video": null,
      "map_id": 34318532,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) It is commonly seen in children. Cryptic miliary tuberculosis typically affects adults more frequently than children. It is characterized by a chronic, subtle progression, with patients presenting with nonspecific symptoms such as mild fever, anemia, and weight loss. Although children can develop miliary tuberculosis, it is not commonly seen in children. In fact, miliary tuberculosis is more often seen in immunocompromised adults, particularly those with HIV or malnutrition. Why the other options are correct: A. It has a chronic course: This is correct. Cryptic miliary tuberculosis usually has a chronic course, with a gradual onset of symptoms. Patients may present with nonspecific symptoms that can be easily overlooked, making the diagnosis more difficult. The disease progresses slowly and often presents with mild fever, weight loss, and general malaise. B. It causes mild intermittent fever and anemia: This is correct. One of the hallmark features of cryptic miliary tuberculosis is the presence of mild intermittent fever and anemia. These symptoms are part of the generalized systemic response to infection, and anemia results from chronic disease and bone marrow suppression. Mild fever is often intermittent and can be mistaken for other less serious conditions. C. Meningeal involvement precedes death: This is correct. Meningeal involvement in cryptic miliary tuberculosis can occur in severe cases, and it is often the leading cause of death in these patients. Meningitis due to miliary tuberculosis can be particularly challenging to diagnose, and it may lead to neurological deterioration and death if not recognized and treated promptly.",
      "correct_choice_id": 216812,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76193,
      "choices": [
        {
          "id": 216813,
          "text": "flu like syndrome is usually seen with rifampicin being taken on daily basis"
        },
        {
          "id": 216814,
          "text": "ethambutol accumulates in renal failure"
        },
        {
          "id": 216815,
          "text": "hyperuricemia is recognised side effect of pyrazinamide"
        },
        {
          "id": 216816,
          "text": "red green colour impairement is an early sign of ethambutol induced optic neuritis"
        }
      ],
      "text": "All of the following are true about the therapy of tuberculosis except:",
      "unique_key": "Q2218245",
      "question_audio": null,
      "question_video": null,
      "map_id": 34665078,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) flu-like syndrome is usually seen with rifampicin being taken on a daily basis. Rifampicin is an essential drug in the treatment of tuberculosis (TB), but flu-like syndrome is not a common side effect of rifampicin, particularly when taken on a daily basis. While it may cause side effects such as hepatotoxicity or rash, flu-like symptoms are more likely to occur with intermittent dosing schedules (e.g., thrice-weekly dosing) or in the presence of drug-drug interactions. Rifampicin can also cause red-orange discoloration of bodily fluids but is not typically associated with flu-like symptoms when taken daily. Why the other options are correct: B. Ethambutol accumulates in renal failure: This is correct. Ethambutol is primarily excreted by the kidneys, and in renal failure, its levels may accumulate, increasing the risk of toxicity. Ethambutol-induced optic neuritis is a potential adverse effect, and its risk is heightened if the drug accumulates due to impaired renal function. C. Hyperuricemia is a recognized side effect of pyrazinamide: This is correct. Pyrazinamide is a first-line anti-TB drug that can cause hyperuricemia as a side effect. This occurs because pyrazinamide inhibits uric acid excretion, potentially leading to gout or renal problems in susceptible patients. Patients on pyrazinamide should be monitored for elevated uric acid levels. D. Red-green color impairment is an early sign of ethambutol-induced optic neuritis: This is correct. One of the early signs of ethambutol-induced optic neuritis is red-green color impairment, which is often the first visual symptom. This condition can progress to vision loss if not detected and managed early. Ethambutol-induced optic neuritis is dose-dependent, and monitoring of visual acuity is recommended during treatment.",
      "correct_choice_id": 216813,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76194,
      "choices": [
        {
          "id": 216817,
          "text": "Pyrazinamide and any one of the fluoroquinolones"
        },
        {
          "id": 216818,
          "text": "Ethambutol and any one of the fluoroquinolones"
        },
        {
          "id": 216819,
          "text": "Any one of second line aminoglycosides and one of the Fluoroquinolones"
        },
        {
          "id": 216820,
          "text": "Vancomycin and one of the fluoroquinolones"
        }
      ],
      "text": "Extensive drug resistant tuberculosis (XDR-TB) is defined as multidrug resistant TB (MDR- TB) strain that becomes resistant to",
      "unique_key": "Q7465640",
      "question_audio": null,
      "question_video": null,
      "map_id": 34373449,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Any one of second-line aminoglycosides and one of the fluoroquinolones. Extensive drug-resistant tuberculosis (XDR-TB) is a form of multidrug-resistant tuberculosis (MDR-TB) that is defined as TB resistant to: Isoniazid and rifampicin (as in MDR-TB), and Any one of the second-line aminoglycosides (such as amikacin, kanamycin, or capreomycin) and any one of the fluoroquinolones (such as levofloxacin or moxifloxacin). This extended resistance makes XDR-TB much more difficult to treat, requiring more complex and expensive treatment regimens. Why the other options are incorrect: A. Pyrazinamide and any one of the fluoroquinolones: This is incorrect because XDR-TB does not specifically require resistance to pyrazinamide. Resistance to pyrazinamide can occur in MDR-TB, but it is not a defining characteristic of XDR-TB. The defining feature of XDR-TB involves resistance to second-line aminoglycosides and fluoroquinolones, not just pyrazinamide. B. Ethambutol and any one of the fluoroquinolones: This is incorrect because ethambutol resistance is not a defining characteristic of XDR-TB. While ethambutol resistance can be seen in MDR-TB, it is not part of the criteria for XDR-TB. The key factors are resistance to fluoroquinolones and second-line aminoglycosides. D. Vancomycin and one of the fluoroquinolones: This is incorrect because vancomycin is not typically used in the treatment of tuberculosis. Vancomycin is an antibiotic used to treat gram-positive infections, not tuberculosis. XDR-TB is specifically defined by resistance to second-line TB drugs, not vancomycin.",
      "correct_choice_id": 216819,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76195,
      "choices": [
        {
          "id": 216821,
          "text": "Not resistant to bacteria"
        },
        {
          "id": 216822,
          "text": "Not resistant to virus"
        },
        {
          "id": 216823,
          "text": "Not resistant to oil"
        },
        {
          "id": 216824,
          "text": "Not resistant to mycobacteria"
        }
      ],
      "text": "What does N in N-95 mask stands for ?",
      "unique_key": "Q4710868",
      "question_audio": null,
      "question_video": null,
      "map_id": 34076021,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Not resistant to oil. The \"N\" in N-95 refers to the mask's resistance to oil. Specifically, N-95 masks are designed to filter out at least 95% of airborne particles, including non-oil-based particles, but they are not resistant to oil-based particles. This means that if there is exposure to oil-based aerosols, the mask's efficiency is reduced. The \"N\" designation indicates that the mask is not rated for oil protection, whereas other masks like P95 are designed to provide protection against oil-based particles. Incorrect Responses: A. Not resistant to bacteria: This is incorrect because N-95 masks are designed to filter out particles, including bacteria, to a significant extent. The mask’s effectiveness is based on the filtration of particles with a size of 0.3 microns or larger, which includes many bacterial pathogens. While the N-95 mask is effective against various bacteria, its \"N\" designation does not refer to bacterial resistance. B. Not resistant to virus: This is incorrect because the N-95 mask is effective in filtering out viral particles, especially those transmitted by respiratory droplets, like SARS-CoV-2. The \"N\" does not indicate any lack of resistance to viruses; rather, it indicates resistance to oil particles, which is a different matter entirely. D. Not resistant to mycobacteria: While the N-95 mask can filter out many airborne pathogens, including mycobacteria (like Mycobacterium tuberculosis), the \"N\" designation does not specifically refer to resistance to mycobacteria. The N-95 mask is effective in a variety of environments but its primary indication is the ability to filter out particulate matter, including those from viruses and bacteria, rather than being a specific barrier to mycobacteria.",
      "correct_choice_id": 216823,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76196,
      "choices": [
        {
          "id": 216825,
          "text": "Patients with uncomplicated upper respiratory tract infection, may have mild symptoms such as fever, cough, sore throat, nasal congestion, malaise and headache"
        },
        {
          "id": 216826,
          "text": "Patients (adults) with presence of clinical features of dypnea and or hypoxia, fever, cough, SPO2 24/minute"
        },
        {
          "id": 216827,
          "text": "Children with dyspnea, fever, cough, SpO2 60/min, 2-11 months > 50/min and 1-5years > 40/minute)"
        },
        {
          "id": 216828,
          "text": "Both b and c"
        }
      ],
      "text": "What is moderate COVID-19 pneumonia ?",
      "unique_key": "Q2392335",
      "question_audio": null,
      "question_video": null,
      "map_id": 34634827,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Both B and C. Moderate COVID-19 pneumonia is characterized by the presence of dyspnea (difficulty breathing) and/or hypoxia (low oxygen levels), and it can be observed in both adults and children. In adults, the clinical features include fever, cough, dyspnea, SpO2 24/min. In children, it includes dyspnea, fever, cough, SpO2 60/min, 2-11 months >50/min, and 1-5 years >40/min). Explanation of Incorrect Options: A. Patients with uncomplicated upper respiratory tract infection, may have mild symptoms such as fever, cough, sore throat, nasal congestion, malaise, and headache: This describes mild COVID-19 or upper respiratory tract infection (URI). These patients typically do not have significant respiratory distress or hypoxia and are not classified as having pneumonia. This option is not consistent with moderate COVID-19 pneumonia, which involves more severe respiratory symptoms. B. Patients (adults) with presence of clinical features of dyspnea and/or hypoxia, fever, cough, SpO2 24/minute: This option accurately describes moderate COVID-19 pneumonia in adults. Patients may have significant respiratory symptoms, including dyspnea, hypoxia, and increased respiratory rate, which fits the criteria for moderate pneumonia. C. Children with dyspnea, fever, cough, SpO2 60/min, 2-11 months >50/min, and 1-5 years >40/minute): This option correctly identifies the clinical features of moderate COVID-19 pneumonia in children. Tachypnea (rapid breathing) based on age group and hypoxia (SpO2 < 94%) are key indicators.",
      "correct_choice_id": 216828,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76197,
      "choices": [
        {
          "id": 216829,
          "text": "Feco oral route"
        },
        {
          "id": 216830,
          "text": "Air droplets"
        },
        {
          "id": 216831,
          "text": "Both"
        },
        {
          "id": 216832,
          "text": "None"
        }
      ],
      "text": "SARS CoV 2 is spread by",
      "unique_key": "Q8022534",
      "question_audio": null,
      "question_video": null,
      "map_id": 34031335,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Both. Explanation: SARS-CoV-2, the virus responsible for COVID-19, can be spread through multiple routes: Respiratory droplets and aerosols – The primary method of transmission. When an infected person coughs, sneezes, talks, or breathes, they release respiratory droplets containing the virus that can be inhaled by others. In enclosed spaces with poor ventilation, aerosol transmission, involving smaller droplets suspended in the air, can also occur. Fecal-oral route – Though less common, there is evidence suggesting that the virus can be found in feces and can be transmitted through contaminated surfaces or improper sanitation. While this is not the main route, it has been documented in certain cases, particularly in patients with gastrointestinal symptoms or poor hygiene practices. Therefore, SARS-CoV-2 can be spread by both respiratory droplets and aerosols, as well as potentially by the fecal-oral route. Explanation of Incorrect Options: Option A: Feco-oral route – Incorrect. The fecal-oral route is not the primary mode of transmission for SARS-CoV-2. While the virus may be found in stool, transmission is primarily through respiratory droplets and aerosols, not via the digestive system. Option B: Air droplets – Incorrect. This option is partially correct but not complete. SARS-CoV-2 is primarily spread through respiratory droplets and aerosols, but it is not limited to just air droplets. The possibility of fecal-oral transmission, although less significant, also exists. Option D: None – Incorrect. SARS-CoV-2 is indeed spread through respiratory droplets and aerosols, as well as the fecal-oral route in some cases, so the answer is not None.",
      "correct_choice_id": 216831,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76198,
      "choices": [
        {
          "id": 216833,
          "text": "It’s order is nidovirales"
        },
        {
          "id": 216834,
          "text": "It belongs to family Coronaviridae"
        },
        {
          "id": 216835,
          "text": "It belongs to subfamiliy orthocoronavirinae"
        },
        {
          "id": 216836,
          "text": "All of the above"
        }
      ],
      "text": "True statement for SARS CoV-2 is ?",
      "unique_key": "Q3319223",
      "question_audio": null,
      "question_video": null,
      "map_id": 34584425,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All of the above. Explanation: SARS-CoV-2, the virus that causes COVID-19, belongs to a specific taxonomic classification: Option A: It’s order is Nidovirales – Correct. SARS-CoV-2 is a member of the order Nidovirales, which includes viruses that have a characteristic large RNA genome. This order consists of viruses that can cause infections in humans and animals, such as coronaviruses and arteriviruses. Option B: It belongs to family Coronaviridae – Correct. SARS-CoV-2 belongs to the family Coronaviridae. This family includes a wide range of viruses that infect mammals and birds, with coronaviruses being known for their distinctive crown-like appearance due to the spike proteins on their surface. Other coronaviruses in this family include SARS-CoV and MERS-CoV. Option C: It belongs to subfamily Orthocoronavirinae – Correct. Within the family Coronaviridae, SARS-CoV-2 is classified under the subfamily Orthocoronavirinae, which encompasses all coronaviruses that primarily affect humans and other animals. This subfamily contains several genera, including Alphacoronavirus, Betacoronavirus (which includes SARS-CoV-2), Gammacoronavirus, and Deltacoronavirus.",
      "correct_choice_id": 216836,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76199,
      "choices": [
        {
          "id": 216837,
          "text": "NRTI"
        },
        {
          "id": 216838,
          "text": "NNRTI"
        },
        {
          "id": 216839,
          "text": "Protease inhibitors"
        },
        {
          "id": 216840,
          "text": "Integrase inhibitors"
        }
      ],
      "text": "Which anti HIV drugs were used to treat COVID-19",
      "unique_key": "Q6973976",
      "question_audio": null,
      "question_video": null,
      "map_id": 34127701,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Protease inhibitors. Explanation: Protease inhibitors (PIs), particularly lopinavir/ritonavir, were initially used to treat COVID-19 patients. These drugs are part of the antiretroviral therapy for HIV and were repurposed during the early stages of the COVID-19 pandemic based on the similarity between the SARS-CoV-2 virus and HIV in terms of viral replication processes. Lopinavir and ritonavir inhibit the viral protease enzyme, which is essential for the virus to mature and replicate. Despite early interest, clinical trials later showed limited effectiveness for COVID-19 treatment, but protease inhibitors were one of the first HIV drugs considered. Incorrect options: Option A: NRTI (Nucleoside Reverse Transcriptase Inhibitors) – Incorrect. While NRTIs are used in HIV treatment to inhibit the reverse transcriptase enzyme, they were not a primary treatment strategy for COVID-19. NRTIs, such as zidovudine and lamivudine, do not have direct efficacy against the SARS-CoV-2 virus. Option B: NNRTI (Non-Nucleoside Reverse Transcriptase Inhibitors) – Incorrect. NNRTIs, such as efavirenz and nevirapine, also target reverse transcriptase in HIV but were not commonly used to treat COVID-19. These drugs are not known to have significant antiviral activity against SARS-CoV-2. Option D: Integrase inhibitors – Incorrect. Integrase inhibitors like dolutegravir and raltegravir are used in HIV therapy to block the integrase enzyme, preventing the viral DNA from integrating into the host genome. While these drugs are highly effective in HIV, they were not prioritized for COVID-19 treatment, as they do not directly inhibit SARS-CoV-2 replication.",
      "correct_choice_id": 216839,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76200,
      "choices": [
        {
          "id": 216841,
          "text": "Zidovudine"
        },
        {
          "id": 216842,
          "text": "Nevirapine"
        },
        {
          "id": 216843,
          "text": "Ritonavir/lopinavir"
        },
        {
          "id": 216844,
          "text": "Dolutegravir"
        }
      ],
      "text": "Which anti HIV drugs were used to treat COVID-19",
      "unique_key": "Q7900238",
      "question_audio": null,
      "question_video": null,
      "map_id": 34425425,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Ritonavir/lopinavir. Explanation: Ritonavir/lopinavir was one of the main antiretroviral combinations considered for the treatment of COVID-19 during the early stages of the pandemic. Both ritonavir and lopinavir are protease inhibitors that work by inhibiting the replication of the virus. Ritonavir, in particular, is often used as a \"booster\" for other protease inhibitors like lopinavir. The combination was investigated for its potential to reduce viral replication in SARS-CoV-2, the virus responsible for COVID-19, although subsequent studies did not support its effectiveness as a treatment for COVID-19. Incorrect Responses: A. Zidovudine: Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI) used primarily in the treatment of HIV. While NRTIs have antiviral properties, they were not specifically used in the treatment of COVID-19. B. Nevirapine: Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in HIV treatment. Like zidovudine, nevirapine was not a focus for COVID-19 therapy. D. Dolutegravir: Dolutegravir is an integrase inhibitor used to treat HIV. While it is a critical drug for HIV management, it was not widely investigated or used for treating COVID-19.",
      "correct_choice_id": 216843,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76201,
      "choices": [
        {
          "id": 216845,
          "text": "Ivermectin"
        },
        {
          "id": 216846,
          "text": "Pyrantel"
        },
        {
          "id": 216847,
          "text": "Albendazole"
        },
        {
          "id": 216848,
          "text": "Mebendazole"
        }
      ],
      "text": "Which anti helminthic is under trials /to treat COVID-19 ?",
      "unique_key": "Q4492037",
      "question_audio": null,
      "question_video": null,
      "map_id": 34410930,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Ivermectin. Explanation: Ivermectin is an anti-helminthic medication that has been investigated for potential use in treating COVID-19. Ivermectin has antiviral properties in vitro and was considered as a possible treatment for SARS-CoV-2 during the early phases of the pandemic. It is thought to inhibit the replication of the virus by interfering with the viral protein transport within host cells. However, while early laboratory studies showed promising results, larger clinical trials have yielded mixed outcomes, and its use for COVID-19 is not widely recommended outside of research settings. Incorrect Responses: B. Pyrantel: Pyrantel is an anti-helminthic used primarily for treating intestinal parasitic infections, such as pinworms. There is no significant evidence to suggest that pyrantel is effective against COVID-19. C. Albendazole: Albendazole is another anti-helminthic drug used to treat a variety of parasitic infections. While it has broad-spectrum activity against helminths, there is no evidence to support its use in the treatment of COVID-19. D. Mebendazole: Mebendazole is used to treat parasitic worm infections, similar to albendazole, and has no proven efficacy in treating COVID-19.",
      "correct_choice_id": 216845,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76202,
      "choices": [
        {
          "id": 216849,
          "text": "1 feet"
        },
        {
          "id": 216850,
          "text": "2 feet"
        },
        {
          "id": 216851,
          "text": "6 feet"
        },
        {
          "id": 216852,
          "text": "4 feet"
        }
      ],
      "text": "Minimum distance to be maintained from a person who is sneezing or coughing is",
      "unique_key": "Q3096425",
      "question_audio": null,
      "question_video": null,
      "map_id": 34504528,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) 6 feet. Explanation: According to health guidelines, it is recommended to maintain a minimum distance of 6 feet (approximately 2 meters) from a person who is sneezing or coughing. This distance is based on the understanding that respiratory droplets, which may carry viruses like SARS-CoV-2, can travel up to 6 feet before falling to the ground. By maintaining this distance, you reduce the risk of inhaling these droplets, thus minimizing the chance of transmission. Incorrect Responses: A. 1 foot: This is too short a distance and does not provide sufficient protection. Respiratory droplets can travel much farther than 1 foot, especially when a person is sneezing or coughing. B. 2 feet: While this is a better distance than 1 foot, it is still not sufficient to reduce the risk of virus transmission effectively. The 6 feet distance is scientifically supported as being more protective. D. 4 feet: While a distance of 4 feet may offer some protection, it is still not the recommended distance. The 6 feet distance is widely accepted as a safer standard.",
      "correct_choice_id": 216851,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76203,
      "choices": [
        {
          "id": 216853,
          "text": "A type of RNA"
        },
        {
          "id": 216854,
          "text": "Type of coronavirus"
        },
        {
          "id": 216855,
          "text": "Under trial vaccine"
        },
        {
          "id": 216856,
          "text": "Drug for treating coronavirus"
        }
      ],
      "text": "What is mRNA-173 ?",
      "unique_key": "Q6947821",
      "question_audio": null,
      "question_video": null,
      "map_id": 34506493,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Under trial vaccine. Explanation: mRNA-173 refers to a vaccine that is currently under trial. It is an experimental mRNA-based vaccine developed to combat COVID-19. The mRNA vaccines work by instructing cells to produce a protein similar to the spike protein of the SARS-CoV-2 virus, thereby stimulating an immune response that helps protect the body from infection. This vaccine is part of a newer approach to vaccine development and is being evaluated in clinical trials to determine its safety and efficacy. Incorrect Responses: A. A type of RNA: mRNA (messenger RNA) is a type of RNA, but mRNA-173 specifically refers to a vaccine candidate, not a generic type of RNA. So, this is not the correct answer. B. Type of coronavirus: mRNA-173 is not a type of coronavirus. It is a vaccine being developed to prevent infection by the SARS-CoV-2 virus, which causes COVID-19, but it is not related to the virus itself. D. Drug for treating coronavirus: mRNA-173 is not a drug for treating COVID-19. It is a preventive vaccine. Treatments for COVID-19 would involve antivirals or other supportive medications, whereas mRNA-173 is designed to prevent infection by stimulating an immune response.",
      "correct_choice_id": 216855,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76204,
      "choices": [
        {
          "id": 216857,
          "text": "Injecting plasma of sick person in its own body"
        },
        {
          "id": 216858,
          "text": "Injecting plasma of healthy person in another healthy person"
        },
        {
          "id": 216859,
          "text": "Injecting plasma of recovered person in sick person"
        },
        {
          "id": 216860,
          "text": "Injecting plasma of healthy person in sick person"
        }
      ],
      "text": "Convalescent plasma therapy means ?",
      "unique_key": "Q2708567",
      "question_audio": null,
      "question_video": null,
      "map_id": 34227801,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Injecting plasma of recovered person in sick person. Explanation: Convalescent plasma therapy involves the use of blood plasma from individuals who have recovered from a particular illness, such as COVID-19, to treat patients who are currently sick with the same illness. The plasma contains antibodies that the recovered person’s immune system developed during their infection, which can help the sick person fight the infection. This therapy is based on the idea that the passive transfer of antibodies may provide immediate immunity and support to the infected patient. Incorrect Responses: A. Injecting plasma of sick person in its own body: This option is incorrect because the therapy does not involve reinjecting plasma from a sick person into their own body. Convalescent plasma therapy is about transferring plasma from a recovered patient to a sick patient, not self-administering plasma from the same individual. B. Injecting plasma of healthy person in another healthy person: This is incorrect because convalescent plasma therapy requires plasma from a recovered person (not necessarily a \"healthy\" person) who has antibodies to the disease, and it is used to treat a sick person, not another healthy person. D. Injecting plasma of healthy person in sick person: This option is incorrect because plasma from a healthy person would not have the necessary antibodies needed to treat the infection. Only plasma from a recovered person who has been exposed to the virus contains the antibodies needed for therapy.",
      "correct_choice_id": 216859,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76205,
      "choices": [
        {
          "id": 216861,
          "text": "Passive immunity"
        },
        {
          "id": 216862,
          "text": "Active immunity"
        },
        {
          "id": 216863,
          "text": "Cellular immunity"
        },
        {
          "id": 216864,
          "text": "Herd immunity"
        }
      ],
      "text": "Concept of plasma therapy is based on ?",
      "unique_key": "Q1368020",
      "question_audio": null,
      "question_video": null,
      "map_id": 34206214,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Passive immunity. Explanation: The concept of plasma therapy is based on passive immunity, which involves transferring antibodies from an immune individual to a susceptible individual. In convalescent plasma therapy, the plasma from a person who has recovered from an illness (such as COVID-19) contains antibodies that the immune system of the recovered person has produced to fight the disease. When this plasma is transferred to a sick patient, these pre-formed antibodies provide immediate immune protection, helping the patient’s body fight off the infection. This type of immunity does not require the recipient’s body to produce antibodies on its own but instead receives them from an external source. Incorrect Responses: B. Active immunity: Active immunity occurs when an individual’s own immune system is exposed to a pathogen (such as through vaccination or infection), and the body produces its own antibodies. In contrast, plasma therapy does not rely on the recipient producing their own antibodies but rather involves the direct transfer of antibodies, which is passive immunity. C. Cellular immunity: Cellular immunity involves immune cells like T-cells that help in the immune response against pathogens. Plasma therapy, however, primarily involves antibodies in the plasma, which are part of the humoral immune response, not the cellular immune response. D. Herd immunity: Herd immunity occurs when a significant portion of the population becomes immune to a disease, either through vaccination or previous infection, reducing its spread. Plasma therapy does not involve the concept of herd immunity, as it is focused on providing immunity to an individual rather than a population.",
      "correct_choice_id": 216861,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76206,
      "choices": [
        {
          "id": 216865,
          "text": "Pore size of mask is 95 microns."
        },
        {
          "id": 216866,
          "text": "Blocks atleast 95% of very small test particles test particles"
        },
        {
          "id": 216867,
          "text": "First created in 1995"
        },
        {
          "id": 216868,
          "text": "Its name of the company which first manufactured it"
        }
      ],
      "text": "What is the meaning of N-95 ?",
      "unique_key": "Q2206985",
      "question_audio": null,
      "question_video": null,
      "map_id": 34235108,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Blocks at least 95% of very small test particles. Explanation: The term N-95 refers to a respirator mask that meets the National Institute for Occupational Safety and Health (NIOSH) standard, designed to block at least 95% of airborne particles, including very small particles such as viruses and bacteria. The \"N\" signifies that the mask is not resistant to oil, making it suitable for non-oil-based airborne particles. These masks are widely used for respiratory protection, especially in healthcare settings, during pandemics like COVID-19, to prevent the spread of infections. Incorrect Responses: A. Pore size of mask is 95 microns: This is incorrect because the pore size of an N-95 mask is much smaller than 95 microns. The mask’s filtration mechanism uses electrostatic attraction to trap particles much smaller than the pores themselves. C. First created in 1995: While the N-95 standard has been around for many years, it is not named after its year of creation. The number \"95\" refers specifically to the mask's filtration efficiency, not its date of origin. D. Its name of the company which first manufactured it: This is incorrect as the name \"N-95\" is a standard defined by NIOSH, not a brand or company name. Various manufacturers produce masks that meet the N-95 standard.",
      "correct_choice_id": 216866,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76207,
      "choices": [
        {
          "id": 216869,
          "text": "Emerging international disease"
        },
        {
          "id": 216870,
          "text": "Emerging infectious disease"
        },
        {
          "id": 216871,
          "text": "Effective infectious disease"
        },
        {
          "id": 216872,
          "text": "Efficient immunity drugs"
        }
      ],
      "text": "What does the term EID means ?",
      "unique_key": "Q5567131",
      "question_audio": null,
      "question_video": null,
      "map_id": 34554150,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Emerging infectious disease Explanation: The term Emerging Infectious Disease (EID) refers to infectious diseases that have recently appeared within a population or whose incidence or geographic range is rapidly increasing. These diseases can arise due to various factors such as environmental changes, zoonotic transmission (from animals to humans), mutations in pathogens, or increased global travel. Examples of EIDs include SARS, MERS, and COVID-19. The term is widely used in public health to describe threats requiring heightened awareness and response. Incorrect Responses: A. Emerging international disease: This is incorrect because EID does not specifically refer to diseases that are international or global. EIDs can emerge locally before spreading internationally, but the term focuses on the emergence or re-emergence of infectious diseases, not their global scope. C. Effective infectious disease: This is incorrect as the term \"effective\" is not relevant to the definition. Infectious diseases are not categorized based on their effectiveness but rather on their emergence, transmission, and potential impact. D. Efficient immunity drugs: This is incorrect as the term does not relate to drugs or immunity. While immunity and medications are vital in managing infectious diseases, EID specifically refers to the diseases themselves, not their treatment.",
      "correct_choice_id": 216870,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76208,
      "choices": [
        {
          "id": 216873,
          "text": "0.3mm"
        },
        {
          "id": 216874,
          "text": "0.3 micrometer"
        },
        {
          "id": 216875,
          "text": "0.3 nanometer"
        },
        {
          "id": 216876,
          "text": "0.3 picometer"
        }
      ],
      "text": "In N 95 mask, 95 means 95% protection against particle size of ?",
      "unique_key": "Q6767094",
      "question_audio": null,
      "question_video": null,
      "map_id": 34139400,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) 0.3 micrometer Explanation: The \"95\" in the N95 mask refers to its ability to block at least 95% of airborne particles that are 0.3 micrometers in size. These particles are among the most difficult to filter because they are in the range where particle movement shifts between inertial and Brownian motion. The N95 mask uses electrostatic filtration to capture these small particles, which makes it highly effective in protecting against airborne pathogens, including viruses like SARS-CoV-2. Incorrect Responses: A. 0.3 mm: This is incorrect because 0.3 millimeters (mm) is much larger than the particle size that the N95 mask is designed to filter. Masks are designed for microscopic particles, not macroscopic ones. C. 0.3 nanometer: This is incorrect because 0.3 nanometers (nm) is far smaller than the size of airborne particles the N95 mask targets. For reference, 0.3 nm is close to the size of individual atoms, and masks do not operate at this scale. D. 0.3 picometer: This is incorrect because 0.3 picometers (pm) is even smaller than a nanometer and well beyond the filtration capability or purpose of N95 masks.",
      "correct_choice_id": 216874,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76209,
      "choices": [
        {
          "id": 216877,
          "text": "0.125nm"
        },
        {
          "id": 216878,
          "text": "1.25nm"
        },
        {
          "id": 216879,
          "text": "12.5nm"
        },
        {
          "id": 216880,
          "text": "125nm"
        }
      ],
      "text": "Size of coronavirus is",
      "unique_key": "Q1564775",
      "question_audio": null,
      "question_video": null,
      "map_id": 34704232,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) 125nm Explanation: The size of coronaviruses, including SARS-CoV-2, is approximately 125 nanometers (nm) in diameter. This size places it in the category of viruses that are larger than many other types of viruses but still small enough to be considered nanoscopic. Its size is significant for understanding its filtration by masks like the N95, which can effectively block particles as small as 0.3 micrometers (300 nm). The measurement of 125 nm is consistent with the structural studies of the virus conducted using electron microscopy. Incorrect Responses: A. 0.125nm: This is incorrect because 0.125 nm is far smaller than the actual size of the coronavirus. A measurement this small would be close to atomic dimensions, which does not apply to viruses. B. 1.25nm: This is incorrect because 1.25 nm is still much smaller than the size of SARS-CoV-2. At this scale, only small molecules, such as simple proteins, would be comparable. C. 12.5nm: This is incorrect because 12.5 nm is also significantly smaller than the actual size of the coronavirus. While some viral components might measure this small, the complete virion (virus particle) is about 125 nm in diameter.",
      "correct_choice_id": 216880,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76210,
      "choices": [
        {
          "id": 216881,
          "text": "Blood born"
        },
        {
          "id": 216882,
          "text": "Droplet infection"
        },
        {
          "id": 216883,
          "text": "Airborne infection"
        },
        {
          "id": 216884,
          "text": "All of the above"
        }
      ],
      "text": "Route of transmission of Corona virus infection is/are",
      "unique_key": "Q5745208",
      "question_audio": null,
      "question_video": null,
      "map_id": 34352014,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Droplet infection The primary route of transmission of the coronavirus infection (SARS-CoV-2) is droplet infection. When an infected person coughs, sneezes, talks, or breathes, respiratory droplets containing the virus are released into the air. These droplets can travel up to about 6 feet and can be inhaled by others nearby, causing the spread of the virus. Droplets can also land on surfaces, leading to fomite transmission if a person touches the surface and then touches their face. Incorrect Responses: A. Blood borne: While viruses like HIV or Hepatitis B are primarily spread through blood, SARS-CoV-2 is not typically spread through blood. It mainly spreads via respiratory droplets. There is no significant evidence to suggest that SARS-CoV-2 is a bloodborne virus. C. Airborne infection: Airborne transmission is not the primary mode for SARS-CoV-2. While smaller aerosol particles may remain suspended in the air in certain circumstances, especially in poorly ventilated spaces, droplet transmission remains the dominant mode of spread. Airborne transmission is more significant in specific settings, such as during medical procedures that generate aerosols, but for general community transmission, droplet infection is the most common route. D. All of the above: As explained above, bloodborne transmission and airborne transmission are not the primary methods for the spread of SARS-CoV-2. Therefore, the option \"All of the above\" is incorrect.",
      "correct_choice_id": 216882,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76211,
      "choices": [
        {
          "id": 216885,
          "text": "1-7 days"
        },
        {
          "id": 216886,
          "text": "2-14 days"
        },
        {
          "id": 216887,
          "text": "3-21 days"
        },
        {
          "id": 216888,
          "text": "4-28 days"
        }
      ],
      "text": "Incubation period of corona virus infection is",
      "unique_key": "Q7573550",
      "question_audio": null,
      "question_video": null,
      "map_id": 34181919,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) 2-14 days The incubation period for COVID-19, caused by the SARS-CoV-2 virus, is typically between 2 to 14 days after exposure. This means that after coming into contact with the virus, symptoms may appear anywhere within this timeframe. Most cases show symptoms around 5-6 days post-exposure, but it can be longer for some individuals. The incubation period is important for understanding the potential for transmission and the timing for quarantine or isolation. Incorrect Responses: A. 1-7 days: While it is possible for symptoms to appear within the 1-7 day period, this range is too short to fully capture the typical incubation period of COVID-19, which can last up to 14 days in some cases. The correct range is 2-14 days. C. 3-21 days: Although symptoms can occur later in some individuals, 21 days is outside the typical incubation period for COVID-19. The majority of people develop symptoms within 2-14 days, so this option is too broad. D. 4-28 days: Similar to option C, the upper limit of 28 days is too long for the standard incubation period of COVID-19. Most cases manifest symptoms within the 2-14 day window.",
      "correct_choice_id": 216886,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76212,
      "choices": [
        {
          "id": 216889,
          "text": "10-40%"
        },
        {
          "id": 216890,
          "text": "40-50%"
        },
        {
          "id": 216891,
          "text": ">60%"
        },
        {
          "id": 216892,
          "text": "100%"
        }
      ],
      "text": "In alcohol based sanitizer for coronavirus, preferred ethanol content is",
      "unique_key": "Q9859251",
      "question_audio": null,
      "question_video": null,
      "map_id": 34267875,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) >60% For alcohol-based sanitizers to be effective against coronavirus (SARS-CoV-2), the ethanol content should be greater than 60%. Ethanol concentrations above 60% are proven to be effective in killing viruses by disrupting their lipid membranes, thereby inactivating the virus. The World Health Organization (WHO) recommends that alcohol-based hand sanitizers contain at least 60-80% alcohol to be effective against viruses like SARS-CoV-2. This concentration is high enough to denature the proteins in the virus and prevent its replication. Incorrect Responses: A. 10-40%: Alcohol concentrations in this range are too low to effectively kill the virus. A sanitizer with such a low alcohol concentration would not have the potency needed to destroy the viral envelope or inactivate the virus. B. 40-50%: While this concentration is higher than option A, it is still insufficient to effectively kill SARS-CoV-2. The WHO and CDC recommend a minimum alcohol concentration of 60% for effective virus inactivation. Lower alcohol content may still reduce germs but would not be as effective against viruses like COVID-19. D. 100%: While 100% ethanol may seem like a very strong disinfectant, it is actually less effective at killing some types of viruses, including SARS-CoV-2. Water content in the alcohol mixture is necessary to help the ethanol penetrate the viral membrane. Pure ethanol evaporates too quickly to be effective, so a lower concentration (above 60%) is optimal for disinfection.",
      "correct_choice_id": 216891,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76213,
      "choices": [
        {
          "id": 216893,
          "text": "Drinking alcohol"
        },
        {
          "id": 216894,
          "text": "Taking hot bath"
        },
        {
          "id": 216895,
          "text": "Prevent self from mosquito bite"
        },
        {
          "id": 216896,
          "text": "None of the above"
        }
      ],
      "text": "Following action prevents coronavirus infection",
      "unique_key": "Q3711377",
      "question_audio": null,
      "question_video": null,
      "map_id": 34327068,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) None of the above None of the actions listed in the options effectively prevent coronavirus infection (SARS-CoV-2). The virus primarily spreads through respiratory droplets when an infected person coughs, sneezes, or talks, and it cannot be prevented by drinking alcohol, taking hot baths, or protecting yourself from mosquito bites. To prevent COVID-19, the most effective measures include hand hygiene, social distancing, wearing masks, and vaccination. Incorrect Responses: A. Drinking alcohol: Drinking alcohol does not prevent coronavirus infection. In fact, alcohol consumed in this way does not help fight the virus in your body. While alcohol-based sanitizers (containing at least 60% ethanol) can disinfect surfaces and hands, drinking alcohol does not provide any protection against SARS-CoV-2. B. Taking hot bath: A hot bath cannot kill the coronavirus or protect you from infection. The virus is transmitted primarily through respiratory droplets, and body temperature is not sufficient to prevent the virus. Proper hygiene, wearing masks, and avoiding close contact are the recommended ways to reduce the risk of infection. C. Prevent self from mosquito bite: Mosquitoes are not responsible for spreading COVID-19. The virus spreads primarily through person-to-person contact via respiratory droplets, not through insect bites. Therefore, preventing mosquito bites has no impact on preventing COVID-19 infection.",
      "correct_choice_id": 216896,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76214,
      "choices": [
        {
          "id": 216897,
          "text": "Older person"
        },
        {
          "id": 216898,
          "text": "Persons with co-morbid cardiac conditions"
        },
        {
          "id": 216899,
          "text": "Diabetic and cancer patients"
        },
        {
          "id": 216900,
          "text": "All of the above"
        }
      ],
      "text": "Who is/are at risk of developing serious corona infection",
      "unique_key": "Q5833348",
      "question_audio": null,
      "question_video": null,
      "map_id": 34197906,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All of the above Older persons, people with co-morbid cardiac conditions, and diabetic or cancer patients are all at higher risk of developing severe complications from COVID-19. Research has shown that these groups have a higher likelihood of experiencing more serious outcomes such as severe pneumonia, acute respiratory distress syndrome (ARDS), and even death. Their weakened immune systems or pre-existing health conditions make them more vulnerable to the virus's effects. Older persons: Age is a significant risk factor for severe COVID-19. As individuals age, their immune systems become less effective, which increases their susceptibility to infections, including the coronavirus. Older adults (especially those over 60) have been shown to experience more severe outcomes from the virus. Persons with co-morbid cardiac conditions: Individuals with pre-existing heart conditions, such as hypertension, heart failure, or coronary artery disease, are more vulnerable to the complications of COVID-19. The virus can exacerbate heart-related issues, leading to more severe respiratory problems and cardiovascular stress. Diabetic and cancer patients: People with diabetes and cancer have compromised immune systems, which can make it harder for their bodies to fight off infections like COVID-19. Additionally, diabetes can lead to complications such as poor circulation, which can worsen the prognosis for someone infected with the virus. Cancer patients, especially those undergoing chemotherapy or other treatments, often have weakened immune systems, making them more susceptible to serious infections. Thus, D. All of the above is the correct answer, as all these groups are at higher risk for severe complications from COVID-19. Incorrect Responses: A. Older person: While older persons are at higher risk, they are not the only group at risk. The answer must include other at-risk groups, such as those with underlying health conditions, to be complete. B. Persons with co-morbid cardiac conditions: Cardiac conditions alone are not the only risk factor for severe disease. Without considering other vulnerable groups (such as older individuals, diabetics, or cancer patients), this option is incomplete. C. Diabetic and cancer patients: While diabetes and cancer patients are at increased risk, there are other significant risk factors (such as older age and cardiovascular disease) that must also be considered for the complete picture.",
      "correct_choice_id": 216900,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76215,
      "choices": [
        {
          "id": 216901,
          "text": "Fever, cough and shortness of breath"
        },
        {
          "id": 216902,
          "text": "Fever, rashes and constipation"
        },
        {
          "id": 216903,
          "text": "Fever,cough and palpitation"
        },
        {
          "id": 216904,
          "text": "Fever, cough and perspiration"
        }
      ],
      "text": "Most common symptoms of corona infections are",
      "unique_key": "Q4244815",
      "question_audio": null,
      "question_video": null,
      "map_id": 34180613,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Fever, cough and shortness of breath The most common symptoms of COVID-19 (the disease caused by the novel coronavirus) are fever, cough, and shortness of breath. These symptoms are typically observed in the majority of infected individuals, especially during the early stages of infection. Fever is one of the primary symptoms, as the body raises its temperature to fight off the virus. Cough is another hallmark symptom, which is often dry but can become productive in some cases, as the virus affects the respiratory system. Shortness of breath or difficulty breathing is a more serious symptom that often occurs when the infection worsens, leading to pneumonia or other complications that affect lung function. These symptoms are the classic signs of COVID-19 infection, and when observed together, they are key indicators of potential infection. Incorrect Responses: B. Fever, rashes and constipation: While fever is a common symptom, rashes and constipation are not typical symptoms of COVID-19. Rashes may occur in some individuals as a secondary reaction or due to other causes, but they are not considered common symptoms of the virus. Constipation is not generally associated with COVID-19. C. Fever, cough and palpitation: Although fever and cough are common symptoms of COVID-19, palpitations (a sensation of a fast or irregular heartbeat) are not a characteristic symptom of COVID-19. Palpitations can occur in response to various stressors or health issues, but they are not commonly linked to this viral infection. D. Fever, cough and perspiration: Fever and cough are indeed common symptoms, but perspiration (sweating) is not a typical symptom of COVID-19. While fever may lead to sweating, it is not one of the primary symptoms that health professionals use to diagnose the virus.",
      "correct_choice_id": 216901,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76216,
      "choices": [
        {
          "id": 216905,
          "text": "1 meter"
        },
        {
          "id": 216906,
          "text": "2 meter"
        },
        {
          "id": 216907,
          "text": "3 meter"
        },
        {
          "id": 216908,
          "text": "4 meter"
        }
      ],
      "text": "What is the minimum distance to be maintained between confirmed or suspected cases in fever clinic ?",
      "unique_key": "Q2736000",
      "question_audio": null,
      "question_video": null,
      "map_id": 34743395,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) 1 meter The minimum distance that should be maintained between confirmed or suspected COVID-19 cases in a fever clinic is 1 meter. This is in accordance with guidelines to minimize the risk of droplet transmission, which is the primary mode of spread for the virus. A distance of 1 meter allows for better air circulation and reduces the likelihood of inhaling respiratory droplets from an infected person, thus helping to prevent the spread of the virus in high-risk settings like fever clinics. Incorrect Responses: B. 2 meter: While 2 meters is a common recommendation for physical distancing in public places and some healthcare settings, the minimum recommended distance in fever clinics may vary based on specific guidelines. However, in some guidelines, 1 meter is deemed sufficient for maintaining safe distance in a clinical environment with proper ventilation and protective measures. C. 3 meter: A distance of 3 meters may be appropriate in certain high-risk situations or for aerosol-generating procedures, but generally, a distance of 1 meter is considered sufficient for most interactions involving confirmed or suspected COVID-19 patients in a fever clinic setting. D. 4 meter: A distance of 4 meters is too large and typically not required in most fever clinic settings unless there are specific circumstances where higher risk of transmission is involved. The 1 meter distance is usually considered adequate for maintaining safety in these scenarios.",
      "correct_choice_id": 216905,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76217,
      "choices": [
        {
          "id": 216909,
          "text": "N95 mask"
        },
        {
          "id": 216910,
          "text": "Goggles/visor"
        },
        {
          "id": 216911,
          "text": "Cap"
        },
        {
          "id": 216912,
          "text": "Disposable gown"
        }
      ],
      "text": "Category, I PPE is recommended while performing aerosol generating procedure in a suspected or confirmed COVID-19 case. Category I PPE consists of which of the following in addition to PPE II",
      "unique_key": "Q9485601",
      "question_audio": null,
      "question_video": null,
      "map_id": 34369956,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) N95 mask Category I PPE is required when performing aerosol-generating procedures (AGPs) in suspected or confirmed COVID-19 cases. An N95 mask is a critical component of Category I PPE because it provides a higher level of filtration compared to regular masks and is specifically designed to protect against small airborne particles, such as those produced during AGPs. This mask helps prevent the inhalation of viral particles that may be released into the air during procedures like intubation, suctioning, or nebulization. Incorrect Responses: B. Goggles/visor: Goggles or a face shield are part of the protective gear needed in a healthcare setting, especially for procedures that may expose healthcare workers to splashes or sprays. However, they are not the additional requirement for Category I PPE specifically for aerosol-generating procedures. The focus in Category I PPE is on respiratory protection, like the N95 mask. C. Cap: A cap is generally used in healthcare settings to prevent contamination from hair and scalp. While it is part of some PPE recommendations, it is not specifically an additional requirement for Category I PPE during AGPs. The primary concern in aerosol-generating procedures is respiratory protection, which is why the N95 mask is emphasized. D. Disposable gown: A disposable gown is part of the standard PPE for healthcare workers to prevent direct contact with potentially contaminated surfaces or fluids. However, a disposable gown is already included in the general PPE (Category II), so it is not specifically an additional requirement for Category I PPE during aerosol-generating procedures.",
      "correct_choice_id": 216909,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76218,
      "choices": [
        {
          "id": 216913,
          "text": "CRP"
        },
        {
          "id": 216914,
          "text": "Procalcitonin"
        },
        {
          "id": 216915,
          "text": "Ferritin"
        },
        {
          "id": 216916,
          "text": "D-dimer"
        }
      ],
      "text": "Which of the following test is not recommended to be done on daily basis in a critically ill mechanically ventilated COVID-19 patient?",
      "unique_key": "Q3165750",
      "question_audio": null,
      "question_video": null,
      "map_id": 34100746,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Procalcitonin In critically ill mechanically ventilated COVID-19 patients, Procalcitonin (PCT) is not recommended to be tested on a daily basis. Procalcitonin levels primarily rise in response to bacterial infections and are used to assess the likelihood of bacterial sepsis. Since COVID-19 is a viral infection, and its associated inflammatory response is typically non-bacterial, daily monitoring of procalcitonin does not provide significant value in most cases. This test is more relevant for distinguishing bacterial infections from viral infections, and its role in COVID-19 is more limited, especially when there is no strong suspicion of a secondary bacterial infection. Incorrect Responses: A. CRP (C-reactive protein): CRP is an acute-phase reactant that rises in response to inflammation, and it is commonly monitored in critically ill COVID-19 patients. CRP levels provide information about the inflammatory response in the body and can help track the progression of the disease. In COVID-19, CRP can be elevated due to the body's inflammatory response to the virus, making it a useful test in the management of critically ill patients. C. Ferritin: Ferritin is a marker of iron storage and an acute-phase reactant. It is often elevated in inflammatory conditions, including COVID-19. In severely ill patients, especially those with cytokine storms, ferritin levels can help indicate the severity of the inflammatory response. Monitoring ferritin is useful in guiding therapy and assessing the risk of complications, such as cytokine release syndrome, so it may be recommended as part of ongoing management. D. D-dimer: D-dimer is a fibrin degradation product that is elevated in the presence of clot formation and breakdown. In COVID-19 patients, especially those with severe disease, elevated D-dimer levels can be an indication of increased risk for thrombosis or disseminated intravascular coagulation (DIC). Regular monitoring of D-dimer levels is important in critically ill patients to assess thrombotic risk and guide anticoagulation therapy.",
      "correct_choice_id": 216914,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76219,
      "choices": [
        {
          "id": 216917,
          "text": "Worsening hypercapnia"
        },
        {
          "id": 216918,
          "text": "Respiratory fatigue"
        },
        {
          "id": 216919,
          "text": "Hemodyanamic instability"
        },
        {
          "id": 216920,
          "text": "All of the above"
        }
      ],
      "text": "Indications for endotracheal intubation",
      "unique_key": "Q1402149",
      "question_audio": null,
      "question_video": null,
      "map_id": 34574172,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All of the above Endotracheal intubation is indicated in situations where airway protection, respiratory support, or adequate oxygenation and ventilation are not possible without it. This includes worsening hypercapnia, respiratory fatigue, and hemodynamic instability, all of which are critical conditions that require prompt intervention to maintain respiratory and circulatory function. Worsening hypercapnia: Hypercapnia (elevated carbon dioxide levels in the blood) can occur in patients with respiratory failure when the body is unable to adequately remove CO2. This condition can be life-threatening, and endotracheal intubation is often required to ensure proper ventilation and removal of CO2. Respiratory fatigue: Respiratory fatigue refers to the inability to maintain effective respiratory effort, often due to muscle exhaustion or overuse, leading to a decline in oxygen levels and rising CO2 levels. In these situations, mechanical ventilation via intubation can assist with breathing and relieve the respiratory muscles. Hemodynamic instability: Hemodynamic instability, which refers to an unstable cardiovascular state, often accompanies respiratory failure. If blood pressure and circulation are affected due to inadequate oxygenation, intubation may be necessary to stabilize the patient by ensuring adequate oxygen delivery and removal of carbon dioxide. Therefore, all of these conditions can lead to the need for endotracheal intubation as a life-saving measure to maintain airway patency, oxygenation, and proper ventilation, making Option D the correct answer. Incorrect Responses: A. Worsening hypercapnia: While hypercapnia is a key reason for intubation, it is only one of the possible indications. Intubation would typically be necessary when hypercapnia cannot be corrected with non-invasive methods like CPAP or BiPAP. B. Respiratory fatigue: Respiratory fatigue is another important reason for intubation, but it alone does not fully encompass all the scenarios in which intubation is required. For example, respiratory fatigue can lead to airway obstruction or respiratory failure, which necessitates more comprehensive intervention. C. Hemodynamic instability: Hemodynamic instability also requires intervention, but intubation is typically considered in combination with other factors such as respiratory failure. Hemodynamic instability due to shock or other causes may require a different course of treatment, like fluid resuscitation or vasopressors, alongside intubation.",
      "correct_choice_id": 216920,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76220,
      "choices": [
        {
          "id": 216921,
          "text": "Endotracheal intubation"
        },
        {
          "id": 216922,
          "text": "Nebulizer treatment"
        },
        {
          "id": 216923,
          "text": "Brushing teeth"
        },
        {
          "id": 216924,
          "text": "Open endotracheal suctioning"
        }
      ],
      "text": "Which of the following is not an aerosol generating procedure?",
      "unique_key": "Q2732550",
      "question_audio": null,
      "question_video": null,
      "map_id": 34114805,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Brushing teeth. Brushing teeth is not considered an aerosol-generating procedure (AGP). While it can create some level of droplet exposure due to saliva and mouth rinsing, it does not generate aerosolized particles at a significant level, unlike the other listed procedures. Aerosol-generating procedures involve activities that produce fine airborne particles or droplets that may remain suspended in the air, potentially increasing the risk of transmission of airborne infectious diseases like COVID-19. Incorrect Answers: A. Endotracheal intubation. Endotracheal intubation is considered a high-risk aerosol-generating procedure. During intubation, there is a risk of aerosolization of respiratory secretions, especially if the patient is coughing or has high viral loads, making it a high-risk procedure for transmitting infections like COVID-19. Personal protective equipment (PPE) such as N95 masks or powered air-purifying respirators (PAPR) are recommended for healthcare workers performing this procedure. B. Nebulizer treatment. Nebulizer treatments are classified as aerosol-generating procedures because they involve the delivery of fine mist or aerosolized medication directly into the lungs. This creates respiratory droplets that can linger in the air and pose a risk for infection transmission, particularly in settings where COVID-19 is a concern. Proper precautions and PPE are required for healthcare providers and patients receiving nebulizer therapy. D. Open endotracheal suctioning. Open endotracheal suctioning is another aerosol-generating procedure. It involves the insertion of a suction catheter into the trachea or endotracheal tube to clear secretions, which can trigger coughing and expel respiratory secretions into the air. This can generate aerosols, putting healthcare workers at risk of exposure to pathogens. Appropriate precautions, including the use of N95 masks and other protective equipment, are necessary during this procedure.",
      "correct_choice_id": 216923,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76221,
      "choices": [
        {
          "id": 216925,
          "text": "Red bag"
        },
        {
          "id": 216926,
          "text": "White bin"
        },
        {
          "id": 216927,
          "text": "Green bag"
        },
        {
          "id": 216928,
          "text": "Yellow bag"
        }
      ],
      "text": "Used N-95 mask is to be disposed off in",
      "unique_key": "Q4314841",
      "question_audio": null,
      "question_video": null,
      "map_id": 34802437,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Yellow bag. Used N-95 masks are considered contaminated due to their exposure to respiratory droplets and potential pathogens. According to guidelines for handling infectious waste, they should be disposed of in a yellow bag, which is designated for biomedical waste. The yellow bag is used for the safe disposal of potentially infectious materials, ensuring that the mask is safely contained and can be processed by a regulated waste management system to prevent the spread of infection. Incorrect Answers: A. Red bag. Red bags are typically used for the disposal of non-infectious waste or waste that does not pose a risk of transmission. They are often used for general waste that does not have significant contamination concerns, such as plastics and other non-hazardous materials. Used N-95 masks, being potentially infectious, do not belong in red bags. B. White bin. White bins are not generally used for the disposal of contaminated medical waste. They are typically designated for the collection of non-hazardous or non-infectious materials. Disposing of used N-95 masks in a white bin would not follow proper infection control protocols. C. Green bag. Green bags are often used for the disposal of biodegradable waste or waste that does not pose a risk of infection. They are not meant for biomedical or infectious waste. Used N-95 masks should not be disposed of in green bags, as they are potentially contaminated and require more secure disposal in a yellow bag.",
      "correct_choice_id": 216928,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76222,
      "choices": [
        {
          "id": 216929,
          "text": "Cap, gloves (first pair), Gown, Neck cover,N-95 mask, eye goggle, head cover nd gloves (2nd pair)"
        },
        {
          "id": 216930,
          "text": "Cap, gown, neck cover, N-95 mask, eye goggle, head cover,Gloves (first pair), and gloves (2nd pair)"
        },
        {
          "id": 216931,
          "text": "N-95 mask, Cap, Gloves (first pair), Gown, neck cover, eye goggle,head cover and glove (second pair)"
        }
      ],
      "text": "Correct sequence of doning of PPE is",
      "unique_key": "Q5663040",
      "question_audio": null,
      "question_video": null,
      "map_id": 34111821,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Cap, gloves (first pair), gown, neck cover, N-95 mask, eye goggle, head cover, and gloves (second pair). The correct sequence for donning personal protective equipment (PPE) follows a logical order to ensure that each item is properly put on without contaminating previously applied gear. The first step is putting on the cap, followed by gloves (first pair), which are used to cover the hands before gowning. The gown is worn next, and then the neck cover is added to protect the neck area. Afterward, the N-95 mask is put on to protect the respiratory system. The eye goggles are worn for eye protection, followed by the head cover to provide additional protection for the head area. Finally, the second pair of gloves is donned over the gown to protect the hands from contamination. Incorrect Answers: B. Cap, gown, neck cover, N-95 mask, eye goggle, head cover, gloves (first pair), and gloves (second pair). This sequence is incorrect because gloves (first pair) should be put on before the gown to avoid contamination of the hands once the gown is on. Additionally, wearing gloves before the gown would compromise the protective barrier created by the gown and could increase the risk of contamination when handling PPE. C. N-95 mask, cap, gloves (first pair), gown, neck cover, eye goggle, head cover, and gloves (second pair). This sequence is also incorrect because the N-95 mask should be the last piece of PPE put on to avoid contamination of the mask while handling other PPE. By putting on the N-95 mask first, it could be compromised or contaminated when the other PPE items are applied. Gloves (first pair) and gown should be donned before the mask for better protection.",
      "correct_choice_id": 216929,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76223,
      "choices": [
        {
          "id": 216932,
          "text": "Shoe cover, head cap, outer gloves, head cover, neck cover, gown, eye goggle, inner gloves and N-95 mask"
        },
        {
          "id": 216933,
          "text": "Shoe cover, outer gloves, head cover, neck cover, gown, eye goggle, inner gloves, N-95 mask and head cap"
        },
        {
          "id": 216934,
          "text": "Head cap, Shoe cover, outer gloves, neck cover, gown, eye goggle, inner gloves and N-95 mask."
        },
        {
          "id": 216935,
          "text": "N-95 mask, shoe cover, outer gloves, head cover, neck cover, gown, eye goggle, inner gloves and head cap"
        }
      ],
      "text": "Correct sequence of doffing COVID-PPE is",
      "unique_key": "Q7068791",
      "question_audio": null,
      "question_video": null,
      "map_id": 34059023,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Shoe cover, outer gloves, head cover, neck cover, gown, eye goggle, inner gloves, N-95 mask, and head cap. The correct sequence for doffing COVID-19 PPE follows a step-by-step order to minimize the risk of contamination during the removal process. First, the shoe cover should be removed, followed by the outer gloves, as they may be contaminated after patient care. Then, the head cover and neck cover are removed to avoid contamination of the face. The gown is removed next to minimize the exposure of body surfaces. After the gown, the eye goggle should be removed. Then, the inner gloves are carefully removed, and finally, the N-95 mask is removed, ensuring minimal exposure to the respiratory system. The last item to be removed is the head cap, as it poses the least risk of contamination when removed last. Incorrect Answers: A. Shoe cover, head cap, outer gloves, head cover, neck cover, gown, eye goggle, inner gloves, and N-95 mask. This sequence is incorrect because the head cap is removed too early in the process. The head cap should be removed last, as it is less likely to be contaminated compared to other PPE items. Removing it earlier could unnecessarily increase the risk of contamination. C. Head cap, shoe cover, outer gloves, neck cover, gown, eye goggle, inner gloves, and N-95 mask. This sequence is also incorrect because the head cap is removed first, which is not recommended. The head cap should be the last piece of PPE removed. In addition, the sequence for removing gloves is out of order. The outer gloves should be removed before the inner gloves to avoid touching contaminated outer surfaces. D. N-95 mask, shoe cover, outer gloves, head cover, neck cover, gown, eye goggle, inner gloves, and head cap. This sequence is incorrect because the N-95 mask should be removed last, not first. Removing the N-95 mask too early can increase the risk of contamination, as it may come into contact with potentially contaminated surfaces or the hands while doffing other PPE.",
      "correct_choice_id": 216933,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76224,
      "choices": [
        {
          "id": 216936,
          "text": "Get HRCT chest, give PCM, steroids and azithromycin"
        },
        {
          "id": 216937,
          "text": "Home isolation, Symptomatic treatment, monitoring of temperature and oxygen saturation"
        },
        {
          "id": 216938,
          "text": "Immediate hospital admission to isolate the patient, steroids, and heparin"
        },
        {
          "id": 216939,
          "text": "Wait till confirmatory RT PCR report for covid"
        }
      ],
      "text": "A 34 year old male presented to fever clinic with 4 days history of fever, sore throat and cough. There is no past medical history. His wife is positive for covid-19 by RT PCR test done 1 week back. On examination his pulse rate is 105/min, BP-110/70 mmHg, temperature is 100 F, respiratory rate is 16/minute and oxygen saturation by pulse oximeter is 97%. Lungs are clear on auscultation. Rapid antigen test for covid is positive. What will be further management?",
      "unique_key": "Q2714366",
      "question_audio": null,
      "question_video": null,
      "map_id": 34008907,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Home isolation, symptomatic treatment, monitoring of temperature and oxygen saturation. The patient presents with mild symptoms (fever, sore throat, and cough) and no respiratory distress, with stable vital signs and oxygen saturation of 97%. The rapid antigen test for COVID-19 is positive, confirming the diagnosis. Given that the patient does not exhibit signs of severe illness (e.g., difficulty breathing, hypoxia, or high fever) and has no underlying comorbidities, home isolation and symptomatic treatment (such as paracetamol for fever) are appropriate. Monitoring of temperature and oxygen saturation is necessary to ensure that the patient's condition does not worsen, which would warrant escalation of care. Incorrect Answers: A. Get HRCT chest, give PCM, steroids, and azithromycin. This option is inappropriate as HRCT of the chest is not indicated in the absence of severe symptoms or clinical signs suggestive of pneumonia or respiratory distress. Steroids and azithromycin should not be routinely administered for mild COVID-19 cases, as they are not effective in the early stages of the disease and could lead to unnecessary side effects. Steroids are typically reserved for moderate to severe cases, and antibiotics like azithromycin are not recommended unless there is a secondary bacterial infection. C. Immediate hospital admission to isolate the patient, steroids, and heparin. Hospital admission is not necessary for a patient with mild symptoms and stable vital signs. There is no indication for steroids or heparin in this case as the patient does not have severe disease or risk factors for thromboembolic complications. Hospital admission should be considered only if the patient's condition worsens (e.g., developing shortness of breath, low oxygen saturation, or significant comorbidities). D. Wait till confirmatory RT-PCR report for COVID. This option is incorrect because the patient has already tested positive for COVID-19 with a rapid antigen test, which is generally sufficient for diagnosis in a symptomatic patient. Waiting for a confirmatory RT-PCR result is unnecessary in this scenario, especially since the patient is symptomatic, and the antigen test result aligns with his clinical presentation and exposure history (his wife tested positive for COVID-19). Immediate management can be initiated based on the positive rapid antigen test.",
      "correct_choice_id": 216937,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76225,
      "choices": [
        {
          "id": 216940,
          "text": "Admit in ICU, oxygen support, iv antibiotics, get HRCT chest"
        },
        {
          "id": 216941,
          "text": "Admit in ICU, oxygen support, iv steroids, injection remdesivir"
        },
        {
          "id": 216942,
          "text": "Admit in ward, oxygen support, iv steroid, heparin"
        },
        {
          "id": 216943,
          "text": "Admit in ward, oxygen support, injection remdesivir, arrange for plasma therapy"
        }
      ],
      "text": "Mr Sunil Kumar a known case of type 2 diabetes and hypertension on regular medicines presented with history of fever and cough for 1 week and shortness of breath for last 1 day. He got covid vaccine 10 days back. Fever was initially low grade now touching 104 F for last 2 days. His requirement for paracetamol has increased from 2 tablets/day to 4 tablets/day. He is taking vitamin c, zinc, ivermectin and doxycycline after teleconsultation. RT-PCR report for covid is positive. On examination he has pulse rate of 95/min, BP-106/60, respiratory rate of 28/minute. Oxygen saturation is 92% on room air. Lung fields are clear. What will be next step of management",
      "unique_key": "Q3556275",
      "question_audio": null,
      "question_video": null,
      "map_id": 34249830,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Admit in ward, oxygen support, IV steroid, heparin. Mr. Sunil Kumar presents with COVID-19 pneumonia (based on fever, cough, shortness of breath, and oxygen saturation of 92%) and underlying comorbidities (type 2 diabetes and hypertension). The patient is showing signs of moderate illness, as evidenced by low oxygen saturation (92%), increased respiratory rate (28/min), and worsening fever. Given these clinical features, the appropriate management involves admission to the ward with oxygen support to correct hypoxia. The use of intravenous steroids (such as dexamethasone) is indicated to manage inflammation in moderate COVID-19 pneumonia. Additionally, heparin is recommended to reduce the risk of thromboembolic events, which is common in COVID-19 patients, especially those with comorbidities. Incorrect Answers: A. Admit in ICU, oxygen support, IV antibiotics, get HRCT chest. This option suggests ICU admission, which is unnecessary at this stage since the patient does not display signs of severe respiratory distress, such as significant hypoxia or need for invasive ventilation. The patient has mild to moderate hypoxia (O2 saturation 92%), which can be managed in the ward. IV antibiotics are not indicated unless there is clinical evidence of a secondary bacterial infection, which is not suggested by the patient's presentation. An HRCT chest is not required as the patient is not showing signs of severe pneumonia; chest imaging is typically reserved for patients with worsening respiratory status or suspected complications. B. Admit in ICU, oxygen support, IV steroids, injection remdesivir. ICU admission is not warranted at this time because the patient's oxygen saturation is not critically low, and he is not in acute respiratory failure. Although IV steroids are appropriate, remdesivir is typically used in the early stages of COVID-19 in hospitalized patients who are not yet severely ill, and its benefit in moderate disease is less established. The need for ICU care should be reconsidered if the patient’s condition deteriorates. D. Admit in ward, oxygen support, injection remdesivir, arrange for plasma therapy. While remdesivir may be used in some cases of moderate COVID-19, there is no strong evidence supporting its use in all patients, especially given the patient's comorbidities and current symptom severity. Plasma therapy is not recommended by most guidelines for COVID-19 management and has not been shown to significantly improve outcomes in patients with moderate disease. The focus should be on oxygen support, steroids, and thromboprophylaxis rather than experimental treatments such as plasma therapy.",
      "correct_choice_id": 216942,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76226,
      "choices": [
        {
          "id": 216944,
          "text": "Oral methylprednisolone can be started if patient improving"
        },
        {
          "id": 216945,
          "text": "CRP monitoring every 48 hours"
        },
        {
          "id": 216946,
          "text": "KFT monitoring every 48 hours"
        },
        {
          "id": 216947,
          "text": "HRCT chest to be done before discharge"
        }
      ],
      "text": "Mr Sunil Kumar(in continuation with question no.2) was admitted in the hospital ward and started on oxygen support, iv methylprednisolone 40 mg twice daily, injection enoxaparin sc 60 mg once daily with supportive treatment. All the following management steps will be correct except",
      "unique_key": "Q1018981",
      "question_audio": null,
      "question_video": null,
      "map_id": 34717870,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer(D) HRCT chest to be done before discharge. An HRCT chest is not routinely required before discharge in a patient with moderate COVID-19 pneumonia who is improving clinically. While imaging may be necessary in some cases if there is concern for complications such as pneumonia, pleural effusion, or pulmonary embolism, it is not indicated solely for discharge. The patient's clinical progress, oxygen saturation, and other vital parameters are the primary indicators for discharge readiness, rather than imaging results. In many cases, the patient’s clinical recovery is more reliable than a chest CT in determining readiness for discharge. Incorrect Answers: A. Oral methylprednisolone can be started if the patient is improving. Oral methylprednisolone is an appropriate step if the patient's condition improves. Once a patient shows signs of recovery and does not require high-dose IV steroids for inflammation management, the oral form can be transitioned, which helps in weaning off steroids gradually. This approach aligns with the step-down process in steroid management for COVID-19 pneumonia. B. CRP monitoring every 48 hours. C-reactive protein (CRP) is a marker of inflammation and can help monitor the inflammatory response in COVID-19 patients. Monitoring CRP levels every 48 hours is a reasonable step in tracking disease progression or resolution, as CRP can reflect ongoing systemic inflammation and guide decisions about the need for continued steroid therapy. C. KFT monitoring every 48 hours. Kidney function tests (KFT) should be monitored regularly, especially in COVID-19 patients who are receiving medications like methylprednisolone and enoxaparin. These medications can potentially affect renal function. Monitoring every 48 hours is a prudent step to detect any early signs of kidney impairment, particularly in patients with pre-existing comorbidities like hypertension and diabetes.",
      "correct_choice_id": 216947,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76227,
      "choices": [
        {
          "id": 216948,
          "text": "Negative RT PCR test before discharge"
        },
        {
          "id": 216949,
          "text": "Afebrile without antipyretics"
        },
        {
          "id": 216950,
          "text": "No oxygen requirement"
        },
        {
          "id": 216951,
          "text": "All"
        }
      ],
      "text": "For clinical scenario in question 2,patient responded to treatment and fever resolved within 3 days of admission.He is maintaining oxygen saturation above 95%. You are planning to discharge the patient from hospital.Which of the following criteria is NOT true regarding the discharge",
      "unique_key": "Q2515727",
      "question_audio": null,
      "question_video": null,
      "map_id": 34033927,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct answer (A) Negative RT PCR test before discharge. A negative RT-PCR test is not required for discharge in most COVID-19 management guidelines. Patients can be discharged based on clinical improvement, such as being afebrile, maintaining oxygen saturation above 95%, and having no oxygen requirements, even if the RT-PCR remains positive. The decision to discharge is based more on clinical stability and recovery rather than the resolution of the virus itself, as patients may continue to test positive even after they have recovered and are no longer infectious. The focus is on the patient's overall condition, not the RT-PCR result. Incorrect Answers: B. Afebrile without antipyretics. Being afebrile without the need for antipyretics is a key criterion for discharge. If the patient has been without fever for at least 24-48 hours without the use of fever-reducing medications, this suggests that the infection is under control and the patient is in the recovery phase. This is an important marker for discharge readiness. C. No oxygen requirement. The absence of oxygen requirement is another important criterion for discharge. The patient must be able to maintain adequate oxygen saturation levels (typically above 94-95%) on room air without requiring supplemental oxygen, which indicates that their respiratory status has improved and they no longer need intensive care. D. All. Option \"All\" is incorrect because the statement regarding the negative RT-PCR test is the only criterion that is not required for discharge. Clinical improvement, including being afebrile, maintaining oxygen saturation without supplemental oxygen, and being stable, are the primary factors for discharge eligibility.",
      "correct_choice_id": 216948,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76228,
      "choices": [
        {
          "id": 216952,
          "text": "Get a repeat RT PCR for covid,oxygen support,start favipiravir,keep in emergency observation till report"
        },
        {
          "id": 216953,
          "text": "Admit in ward,oxygen support,start iv steroids+enoxaparin"
        },
        {
          "id": 216954,
          "text": "Admit in ICU,oxygen support,start iv steroids+enoxaparin"
        },
        {
          "id": 216955,
          "text": "Admit in ICU,oxygen support,iv remdesivir+plasma therapy"
        }
      ],
      "text": "A 38 year old female presented to AIIMS emergency with complaints of fever for 12 days. She developed severe cough with shortness of breath for last 2 days. RT-PCR is positive for covid infection .HRCT chest which she got done showed diffuse ground glass opacities involving 70% of lung fields. On examination she is tachypnic, repiratory rate of 30/min with use of accessory muscles of respiration. Pulse rate is 120/min,BP-120/70 mmHg and oxygen saturation 88% on room air.What will be the next line of management for her?",
      "unique_key": "Q9675101",
      "question_audio": null,
      "question_video": null,
      "map_id": 34167302,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Admit in ICU, oxygen support, start IV steroids + enoxaparin. This patient presents with severe symptoms of COVID-19, including tachypnea (respiratory rate of 30/min), use of accessory muscles of respiration, and low oxygen saturation (88% on room air). The HRCT chest shows diffuse ground-glass opacities involving 70% of the lung fields, which suggests significant lung involvement, indicative of moderate to severe COVID-19 pneumonia. Given the clinical presentation and signs of respiratory distress, the patient should be admitted to the ICU for close monitoring and advanced management. Oxygen support is crucial to address hypoxia, and intravenous steroids (such as dexamethasone) are indicated to reduce inflammation in moderate-to-severe COVID-19 pneumonia. Enoxaparin (low molecular weight heparin) is also recommended for thromboprophylaxis, as COVID-19 patients are at higher risk of thromboembolic events. Incorrect Answers: A. Get a repeat RT PCR for COVID, oxygen support, start favipiravir, keep in emergency observation till report. This option is not appropriate because a repeat RT-PCR is unnecessary as the initial test is already positive. The patient requires immediate treatment due to her severe symptoms, and delaying care while awaiting another PCR result is not advisable. Favipiravir is not routinely recommended in severe COVID-19 cases, and the patient’s oxygen saturation and respiratory status require urgent intervention in the ICU, not merely observation. B. Admit in ward, oxygen support, start IV steroids + enoxaparin. While this option includes the appropriate therapies (oxygen support, IV steroids, and enoxaparin), it is not appropriate to admit this patient to the ward. Given the patient's respiratory distress (tachypnea, use of accessory muscles, and hypoxia), ICU admission is warranted for close monitoring and more intensive care, including possible escalation of oxygen therapy if needed. Ward care is generally for patients who do not have signs of severe distress and whose oxygen saturation can be maintained without intensive interventions. D. Admit in ICU, oxygen support, IV remdesivir + plasma therapy. While remdesivir may be considered for certain COVID-19 patients, its use is not universally indicated for all patients, especially in severe cases, and its benefit in terms of improving outcomes is limited. Plasma therapy is no longer recommended in most guidelines, as there is insufficient evidence to support its efficacy in reducing mortality or improving recovery. IV steroids and enoxaparin are the mainstay of treatment for severe COVID-19 pneumonia, and remdesivir or plasma therapy is not typically prioritized unless specifically indicated in the clinical protocol.",
      "correct_choice_id": 216954,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76229,
      "choices": [
        {
          "id": 216956,
          "text": "Remdesivir"
        },
        {
          "id": 216957,
          "text": "Tocilizumab"
        },
        {
          "id": 216958,
          "text": "Plasma therapy"
        },
        {
          "id": 216959,
          "text": "All the above"
        }
      ],
      "text": "In clincal scenario of question no. 4, patient was started on appropriate treatment. But even after 48 hours her condition is deteriorating with oxygen saturation is falling even with high flow oxygen.Which of the following treatment options can be considered for her",
      "unique_key": "Q4826447",
      "question_audio": null,
      "question_video": null,
      "map_id": 34090318,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Tocilizumab. Tocilizumab, an interleukin-6 (IL-6) receptor antagonist, is indicated in COVID-19 patients with severe disease who are showing signs of systemic inflammation and are deteriorating despite standard therapy (including oxygen support and steroids). This medication can help reduce the inflammatory cytokine storm seen in severe COVID-19 and has been shown to improve outcomes in certain patients, particularly when administered early in the course of worsening disease. It can be considered when a patient’s oxygen saturation continues to drop despite high-flow oxygen, and the patient exhibits elevated inflammatory markers such as CRP or ferritin, suggesting a hyperinflammatory response. Incorrect Answers: A. Remdesivir. Remdesivir is an antiviral medication that is used early in the disease course to inhibit viral replication in patients with moderate-to-severe COVID-19. However, its efficacy in patients who are already showing signs of worsening disease despite 48 hours of treatment is limited. Remdesivir is typically recommended in the earlier stages of COVID-19 to reduce viral load, and its benefit in advanced stages of severe disease or during the inflammatory phase is not well-established. Since the patient is deteriorating despite high-flow oxygen, remdesivir would not be the first treatment choice at this point. C. Plasma therapy. Plasma therapy (convalescent plasma) was considered an option for treating COVID-19 in the early stages of the pandemic, but recent evidence has shown it to be ineffective in improving patient outcomes in severe COVID-19. It is no longer recommended as a standard treatment, as it has not demonstrated significant benefit in reducing mortality or improving clinical recovery. Current guidelines do not prioritize plasma therapy for patients who are deteriorating, making it an inappropriate treatment option at this stage. D. All the above. Since remdesivir and plasma therapy are not recommended for this patient's condition, \"all the above\" is incorrect. The most appropriate choice for a patient deteriorating despite oxygen support is tocilizumab, particularly if there is evidence of an inflammatory response, as it targets the cytokine storm and can help in managing the worsening respiratory status.",
      "correct_choice_id": 216957,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76230,
      "choices": [
        {
          "id": 216960,
          "text": "Negative RT PCR test"
        },
        {
          "id": 216961,
          "text": "Clinical recovery"
        },
        {
          "id": 216962,
          "text": "Both"
        },
        {
          "id": 216963,
          "text": "None"
        }
      ],
      "text": "The above mentioned patient gradually improved with treatment in hospital.It is her 10 th day in hospital.You are planning to discharge the patient.Which of the following criteria will be considered for her discharge",
      "unique_key": "Q8317759",
      "question_audio": null,
      "question_video": null,
      "map_id": 34358592,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Both. The discharge criteria for a patient recovering from COVID-19 typically include both clinical recovery and a negative RT-PCR test, although the latter may vary based on the guidelines and the patient's individual situation. Clinical recovery is paramount and involves being afebrile for at least 24-48 hours, maintaining adequate oxygen saturation (above 94-95% on room air), and showing overall improvement in symptoms. In many cases, if the patient is stable and meets these criteria, discharge is considered even if the RT-PCR test remains positive. However, in some settings, a negative RT-PCR result is still considered before discharge, particularly in countries or institutions that mandate such testing for infection control purposes. Therefore, both clinical recovery and a negative RT-PCR test are often part of the discharge criteria. Incorrect Answers: A. Negative RT PCR test. A negative RT-PCR test is not always required for discharge, especially in the later stages of recovery. Many patients continue to test positive even after clinical recovery, and a positive test result does not necessarily mean the patient is still infectious. Discharge decisions are generally based more on clinical recovery and the patient's stability rather than on whether the RT-PCR test is negative. In fact, several guidelines now recommend discharge based on clinical criteria rather than a negative test result. B. Clinical recovery. While clinical recovery is a crucial part of the discharge criteria, it alone may not always be sufficient. Although patients who are clinically stable and have improved symptoms can be discharged, some guidelines still consider the RT-PCR result in deciding whether a patient is ready for discharge. Therefore, relying solely on clinical recovery may not align with certain institutional or regional protocols, which is why both clinical recovery and a negative test are often combined in discharge decisions. D. None. This option is incorrect because both clinical recovery and a negative RT-PCR test are commonly considered for discharge, as explained in the correct response. Therefore, \"None\" is not a valid answer.",
      "correct_choice_id": 216962,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76231,
      "choices": [
        {
          "id": 216964,
          "text": "Insulin infusion should be started immediately"
        },
        {
          "id": 216965,
          "text": "Start with Basal bolus insulin regimen"
        },
        {
          "id": 216966,
          "text": "Increase oral anti diabetes agent doses"
        },
        {
          "id": 216967,
          "text": "Target premeal sugar should be 110-150 mg/dl"
        }
      ],
      "text": "A 48 year old male with uncontrolled type 2 diabetes on oral anti diabetes agents presented with history of fever,cough and shortness of breath for last 6 days.His RT PCR test for covid is positive.On examination pulse is 120/min,BP-130/80 mmHg,respiratory rate 32/min,oxygen saturation 86% on room air.Random blood sugar is 300 mg/dl.Blood and urine ketones are negative.He is accepting orally.You admit him in ICU and started covid treatment including iv methylprednisolone,enoxaparin,oxygen support.Which of the following is NOT correct regarding diabetes management",
      "unique_key": "Q8165774",
      "question_audio": null,
      "question_video": null,
      "map_id": 34122753,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Insulin infusion should be started immediately. In patients with uncontrolled type 2 diabetes and acute illness, insulin infusion is generally not the first-line management. Insulin infusion is typically reserved for patients who are critically ill and unable to tolerate oral intake or those with severe hyperglycemia or diabetic ketoacidosis (DKA). This patient, despite having a high blood sugar of 300 mg/dl, is still accepting oral intake, and insulin infusion is not immediately required unless the patient's condition deteriorates or he becomes unable to take oral medications. In such cases, subcutaneous insulin therapy would be a more appropriate initial approach unless there are other complications like DKA. Incorrect Answers: B. Start with Basal-bolus insulin regimen. The basal-bolus insulin regimen is an appropriate choice for managing blood glucose in patients with type 2 diabetes who are hospitalized, especially if they are not able to manage their blood sugar with oral medications alone. This approach provides long-acting (basal) insulin to cover the patient’s background insulin needs and rapid-acting (bolus) insulin to manage the post-meal blood sugar spikes. This strategy is commonly used to avoid large fluctuations in glucose levels and is a safe way to manage hospitalized diabetic patients. C. Increase oral anti-diabetes agent doses. Increasing doses of oral anti-diabetes agents like metformin or sulfonylureas is not recommended in the hospital setting, especially in critically ill patients with uncontrolled blood sugar. Acute illness can significantly affect the way the body handles diabetes, and oral medications may not be sufficient to manage the elevated glucose levels. Moreover, these medications can pose risks in patients with compromised renal function or altered metabolism, as seen in critically ill patients. In this scenario, insulin therapy is preferred over increasing oral medication doses. D. Target premeal sugar should be 110-150 mg/dl. The target premeal blood sugar range of 110-150 mg/dl is appropriate in hospitalized patients with diabetes. Maintaining blood glucose levels within this range can help reduce the risk of complications like hyperglycemia and improve patient outcomes without increasing the risk of hypoglycemia. This target range is aligned with the general recommendations for managing blood sugar in critically ill patients to avoid exacerbating illness and to promote better recovery.",
      "correct_choice_id": 216964,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76232,
      "choices": [
        {
          "id": 216968,
          "text": "No medicines to control sugar as it will improve after stopping steroids"
        },
        {
          "id": 216969,
          "text": "Start metformin 500 mg twice daily"
        },
        {
          "id": 216970,
          "text": "Start insulin with 0.2 units/kg/day"
        },
        {
          "id": 216971,
          "text": "start insulin infusion 0.1 units/kg"
        }
      ],
      "text": "A 50 year old female withour any significant medical history presented with severe covid infection and admitted in ICU.She was staretd on iv steroids,low molecular weight heparin and oxygen support non invasive.2 days later her oxygen requirement reduced but blood glucose increased with fasting value of 210 mg/dl and post prandial 280 mg/dl.There is no evidence of sepsis and ketosis.She is accepting orally.What will be appropriate step to control glucose levels",
      "unique_key": "Q2355018",
      "question_audio": null,
      "question_video": null,
      "map_id": 34230943,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Start insulin with 0.2 units/kg/day. The patient has elevated blood glucose levels, likely induced by the use of steroids, which are known to cause hyperglycemia, especially in patients without pre-existing diabetes. In hospitalized patients, particularly those on steroids, insulin is often required to control blood sugar levels, even if the patient has not been diagnosed with diabetes before. The recommended approach is to start subcutaneous insulin therapy, using a basal-bolus regimen. In this case, starting insulin with a dose of 0.2 units/kg/day is appropriate to manage her elevated blood glucose levels and prevent complications of hyperglycemia. Insulin provides better control over glucose levels compared to oral agents in acute situations, especially in a hospital setting. Incorrect Answers: A. No medicines to control sugar as it will improve after stopping steroids. This option is incorrect because even though steroids can cause hyperglycemia, stopping them does not always result in immediate normalization of blood glucose. Insulin is often required to manage hyperglycemia while the patient is still receiving steroids or during recovery. Relying on the idea that glucose levels will improve on their own is not appropriate in a hospitalized, critically ill patient. Insulin should be used to maintain tight glucose control and prevent complications like infections, poor wound healing, or cardiovascular issues. B. Start metformin 500 mg twice daily. Metformin is generally contraindicated in acutely ill patients, especially those with renal impairment or hypoxia, which can be more common in patients with severe COVID-19. While metformin is a common medication for managing type 2 diabetes, it is not the first-line choice for managing steroid-induced hyperglycemia, especially in the acute setting. Metformin works primarily by improving insulin sensitivity and does not act rapidly enough to control blood glucose in critically ill patients. D. Start insulin infusion 0.1 units/kg. Starting insulin infusion at 0.1 units/kg is typically used for more severely ill patients, especially those in critical conditions such as diabetic ketoacidosis (DKA) or those unable to tolerate oral intake. Since the patient is already accepting oral intake and has stable vital signs with no signs of DKA or infection, a subcutaneous insulin regimen (as mentioned in answer C) is more appropriate and safer than starting an insulin infusion. An insulin infusion is usually reserved for more critical situations where precise control of glucose is needed, and the patient cannot take insulin by injection.",
      "correct_choice_id": 216970,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76233,
      "choices": [
        {
          "id": 216972,
          "text": "Take biopsy from involved area and wait for microbiological confirmation"
        },
        {
          "id": 216973,
          "text": "Minimise or stop dexamethasone"
        },
        {
          "id": 216974,
          "text": "Blood glucose control with insulin"
        },
        {
          "id": 216975,
          "text": "Start Posaconazole even before microbiological confirmation of Mucormycosis"
        }
      ],
      "text": "A 70 year old male developed severe covid infection and was treated in covid dedicated hospital with oxygen,iv dexamethasone,heparin and antibiotics.His fever and inflammatory blood markers normalises but his oxygen saturation remained 90% on room air.He was discharged and advised home oxygen therapy with tapered doses of oral dexamethasone.He returned to OPD after one week complaining of nasal block with brown coloured nasal discharge.He also complaint of facial pain and diplopia.On examination facial swelling on right side is seen with cranial nerve third palsy.Random blood sugar is 270 mg/dl.MRI of paranasal sinus and orbit shows right maxillary sinusitis with orbital extension of inflammation.Which of the following management strategy is NOT suitable for him",
      "unique_key": "Q8180719",
      "question_audio": null,
      "question_video": null,
      "map_id": 34756439,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correction Answer (A) Take biopsy from involved area and wait for microbiological confirmation. In this patient, the clinical presentation, including nasal block, brown-colored discharge, facial swelling, cranial nerve third palsy, and MRI findings of maxillary sinusitis with orbital extension, strongly suggests mucormycosis (a fungal infection), which can occur in patients with severe COVID-19, especially those receiving prolonged corticosteroid therapy. The management of suspected mucormycosis is urgent and should not be delayed by waiting for microbiological confirmation. Biopsy and microbiological confirmation can be time-consuming and may delay the initiation of life-saving antifungal therapy. The treatment for suspected mucormycosis should start immediately based on clinical suspicion and imaging findings, even before microbiological confirmation. Waiting for a biopsy result can result in further progression of the infection and more severe complications, including loss of vision or tissue necrosis. Incorrect Answers: B. Minimise or stop dexamethasone. Dexamethasone is a corticosteroid used to manage severe COVID-19, but it has been associated with increased susceptibility to opportunistic infections such as mucormycosis, especially in diabetic patients or those with uncontrolled blood glucose levels. In this patient, the use of dexamethasone should be minimized or stopped, as it may be contributing to immunosuppression, which facilitates fungal infections like mucormycosis. This approach helps to reduce the risk of further progression of the infection. C. Blood glucose control with insulin. Uncontrolled blood glucose is a significant risk factor for the development and worsening of mucormycosis in patients with COVID-19, especially those on corticosteroids. The patient's blood sugar is elevated (270 mg/dl), and tight glucose control is necessary to reduce the risk of fungal infections. Insulin therapy is the preferred method to achieve good glycemic control, as oral antidiabetic agents would not be effective in this acute setting. Good blood sugar control is essential to improving outcomes in patients with mucormycosis. D. Start Posaconazole even before microbiological confirmation of Mucormycosis. Posaconazole is an antifungal agent used in the treatment of mucormycosis. It is appropriate to start posaconazole or another antifungal treatment immediately in patients with suspected mucormycosis based on clinical presentation and imaging findings. Early initiation of antifungal therapy can significantly improve survival rates in these patients. Therefore, starting posaconazole before microbiological confirmation is a correct and essential step in management to prevent the spread and worsening of the fungal infection.",
      "correct_choice_id": 216972,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76234,
      "choices": [
        {
          "id": 216976,
          "text": "Hypotension"
        },
        {
          "id": 216977,
          "text": "Number of lobes involved"
        },
        {
          "id": 216978,
          "text": "Previous antibiotic use"
        },
        {
          "id": 216979,
          "text": "Organism type and previous intubation"
        }
      ],
      "text": "A 68-year-old man with several days of increasing cough, discolored sputum production, and chest pain arrives at the ED. The pain is sharp, right sided, and worsens when he takes a deep breath. He has had a fever of 102°F at home. The dyspnea markedly worsened today, and that is what made him come to the hospital. BP: 100/56 mm Hg; Pulse: 112 beats/minute; Temperature: 102.8°F; Respiratory rate: 26 breaths/minute. Chest: right-sided crackles in lung field. Abdomen: nontender, no organomegaly Cardiovascular: no murmurs, no gallops. Chest x-ray: right middle and right lower lobe infiltrates; effusion on right side. ABG: pH 7.46; PCO2 34 mm Hg; PO2 65 mm Hg. Which of the following is the greatest determinant of the need for hospital admission?",
      "unique_key": "Q4734434",
      "question_audio": null,
      "question_video": null,
      "map_id": 34770769,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hypotension. This patient presents with signs and symptoms of community-acquired pneumonia (CAP), including cough with discolored sputum, chest pain, fever, and worsening dyspnea. The chest x-ray findings of right middle and lower lobe infiltrates, along with the presence of a right-sided effusion, further support the diagnosis. In this case, hypotension (BP 100/56 mm Hg) is the greatest determinant for hospital admission. Hypotension is a marker of severe infection, which may indicate septic shock or systemic involvement, and it increases the risk of complications like respiratory failure or multi-organ dysfunction. As such, the presence of hypotension is a key factor in deciding whether this patient needs to be admitted for intensive monitoring and treatment. Incorrect Options: B. Number of lobes involved: While pneumonia involving multiple lobes can suggest a more severe infection, the number of lobes involved alone is not the primary determinant for hospital admission. The clinical stability of the patient, including factors like hypotension and oxygenation, plays a more crucial role in the decision to admit. C. Previous antibiotic use: Previous antibiotic use may be relevant in determining antibiotic resistance and guiding treatment, but it does not directly determine whether the patient requires hospital admission. This patient's condition, particularly with hypoxia and hypotension, warrants admission regardless of prior antibiotic use. D. Organism type and previous intubation: While knowledge of the causative organism and the patient's prior medical history (such as previous intubation) can inform treatment strategies, they are not the greatest determinants of hospital admission. The severity of the acute presentation, including hypotension and hypoxia, is a more pressing concern.",
      "correct_choice_id": 216976,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/12195211705049958/12195211705049958.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/12195211705049958/12195211705049958.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76235,
      "choices": [
        {
          "id": 216980,
          "text": "Mycoplasma"
        },
        {
          "id": 216981,
          "text": "S. pneumonia"
        },
        {
          "id": 216982,
          "text": "Mycobacterium TB"
        },
        {
          "id": 216983,
          "text": "Pneumocystis Jiroveci"
        }
      ],
      "text": "A 44-year-old man with acquired immunodeficiency syndrome (AIDS) arrives at the ED with several days of increasing dyspnea and cough. The cough is dry and nonproductive. On examination BP: 108/72 mm Hg; Pulse: 88 beats/minute; Temperature: 101.4°F; Respiratory rate: 26 breaths/minute. General: thin, wasted appearance Chest: clear bilaterally Abdomen: normal Cardiovascular: normal. Reports: ABG: pH 7.49; PCO2 32 mm Hg; PO2 68 mm Hg (on room air), Chest x-ray: bilateral interstitial infiltrates CBC: WBCs 3200/μL (low); LDH: 825 units/L (elevated). What is the likely etiological agent for this pneumonia",
      "unique_key": "Q2715979",
      "question_audio": null,
      "question_video": null,
      "map_id": 34513896,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Pneumocystis jiroveci. This 44-year-old patient with AIDS presents with several days of increasing dyspnea, dry cough, and fever. The key findings that suggest Pneumocystis jiroveci pneumonia (PCP) include: The patient's low CD4 count, which predisposes him to opportunistic infections like PCP. Bilateral interstitial infiltrates on chest x-ray, which are classic for PCP. The patient's low oxygen levels (PO2 of 68 mm Hg), which are typical of PCP, as this infection commonly leads to significant hypoxemia. Elevated LDH, which is often elevated in patients with PCP. Dry, nonproductive cough is a hallmark symptom of PCP. These clinical and laboratory features are strongly suggestive of Pneumocystis jiroveci, a fungal infection that primarily affects immunocompromised individuals, particularly those with AIDS and low CD4 counts. Incorrect Options: A. Mycoplasma: Mycoplasma pneumonia typically causes community-acquired pneumonia in otherwise healthy individuals. The infection tends to present with a productive cough and is less likely to cause severe hypoxemia and bilateral interstitial infiltrates as seen here. While mycoplasma can cause interstitial pneumonia, it is less common in immunocompromised patients compared to Pneumocystis jiroveci. B. S. pneumonia: Streptococcus pneumoniae is a common bacterial cause of pneumonia, particularly in immunocompetent individuals. It typically causes lobar pneumonia rather than the interstitial infiltrates seen in this patient. Additionally, S. pneumoniae would likely be associated with a more productive cough, which this patient does not have, making it less likely in this case. C. Mycobacterium tuberculosis: Mycobacterium tuberculosis can cause pneumonia in immunocompromised individuals, including those with AIDS. However, tuberculosis typically presents with a chronic cough, often productive, and weight loss, which is not reported in this case. Additionally, chest x-ray findings for TB usually show upper lobe infiltrates or cavitary lesions, which are not seen in this patient's x-ray.",
      "correct_choice_id": 216983,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24106621705049987/24106621705049987.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24106621705049987/24106621705049987.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76236,
      "choices": [
        {
          "id": 216984,
          "text": "Cotrimoxazole"
        },
        {
          "id": 216985,
          "text": "Steroids"
        },
        {
          "id": 216986,
          "text": "High flow oxygen"
        },
        {
          "id": 216987,
          "text": "None"
        }
      ],
      "text": "In continuation with previous clinical vignette, patient was admitted. All the following treatment will be useful except",
      "unique_key": "Q3580717",
      "question_audio": null,
      "question_video": null,
      "map_id": 34093860,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) None. For a patient with Pneumocystis jiroveci pneumonia (PCP), which is the most likely diagnosis based on the previous vignette, the standard treatment includes: Cotrimoxazole (A): This is the first-line treatment for PCP. It is a combination of trimethoprim and sulfamethoxazole, which effectively targets Pneumocystis jiroveci. The patient should receive high-dose IV cotrimoxazole initially, and oral therapy may be started once clinically stabilized. Steroids (B): Steroids are recommended as adjunctive therapy for moderate to severe PCP. They help reduce inflammation and improve oxygenation, particularly in patients with significant hypoxemia (PO2 35). The patient’s hypoxemia (PO2 of 68 mm Hg) warrants the use of steroids to reduce inflammation and help improve respiratory function. High flow oxygen (C): This patient has severe hypoxemia (PO2 68 mm Hg), which is a common feature of PCP. High-flow oxygen is often required to manage severe hypoxia and improve oxygenation in patients with PCP. Incorrect Option: D. None: This option is incorrect because all of the above treatments (A, B, C) are appropriate and beneficial for the management of PCP in this patient. Cotrimoxazole, steroids, and high-flow oxygen are all standard treatments in the management of severe Pneumocystis jiroveci pneumonia. Therefore, none of these treatments should be excluded from the management plan.",
      "correct_choice_id": 216987,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/60041881705050003/60041881705050003.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/60041881705050003/60041881705050003.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76237,
      "choices": [
        {
          "id": 216988,
          "text": "Start levofloxacin for 1 week and see the response"
        },
        {
          "id": 216989,
          "text": "Start ATT"
        },
        {
          "id": 216990,
          "text": "Repeat sputum AFB and if negative wait for culture"
        },
        {
          "id": 216991,
          "text": "Get CT chest done"
        }
      ],
      "text": "A 35-year-old male presented with fever, cough, and sputum with hemoptysis developing over 2-3 weeks. The patient has lost 5 kg weight. On examination-BP: 112/70 mm Hg; Temperature:101.4°F; Respiratory rate: 18 breaths/minute. Head, Ears, Eyes, Nose, Throat (HEENT): normal, no adenopathy Chest: left upper site rales present, no bronchial breath sound. Cardiovascular: no murmurs, rubs, gallops.Lab Report: Chest x-ray: apical infiltrate, Oximeter: 95% saturation on room air,sputum Acid-fast stain: positive.What will be next line of management",
      "unique_key": "Q8825947",
      "question_audio": null,
      "question_video": null,
      "map_id": 34041813,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Start ATT (Anti-Tuberculosis Therapy). The patient presents with fever, cough, hemoptysis, weight loss, and a positive acid-fast bacilli (AFB) stain, which are classic signs of pulmonary tuberculosis (TB). The chest x-ray showing apical infiltrates further supports this diagnosis, as TB commonly affects the upper lobes of the lungs. Since the patient has positive sputum AFB, this is a strong indication for starting Anti-Tuberculosis Therapy (ATT) immediately, without waiting for further diagnostic tests. Early initiation of treatment is critical in managing TB, preventing transmission, and reducing complications. Incorrect Options: A. Start levofloxacin for 1 week and see the response: Levofloxacin is a broad-spectrum antibiotic, but it is not the first-line treatment for tuberculosis. TB is caused by Mycobacterium tuberculosis, and the recommended treatment regimen involves a combination of first-line anti-tuberculosis drugs (e.g., isoniazid, rifampin, pyrazinamide, and ethambutol) for an appropriate duration. Levofloxacin may be used in some cases as part of second-line treatment, but it is not a substitute for starting the appropriate ATT regimen in a suspected TB case. C. Repeat sputum AFB and if negative wait for culture: Although sputum AFB smear is a useful diagnostic tool, the positive result in this case already confirms the diagnosis of TB. Waiting for culture results (which can take weeks) is unnecessary when you already have a positive AFB stain and clear clinical findings suggesting TB. Delaying treatment can result in disease progression and further transmission. D. Get CT chest done: A chest CT may be useful in some cases for further evaluation of lung pathology, especially if the diagnosis is unclear or complications are suspected. However, in this case, the patient’s clinical presentation, positive sputum AFB, and chest x-ray findings already point to a diagnosis of pulmonary tuberculosis. The next step should be starting ATT rather than additional imaging studies.",
      "correct_choice_id": 216989,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38528601705050041/38528601705050041.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38528601705050041/38528601705050041.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76238,
      "choices": [
        {
          "id": 216992,
          "text": "SpO2<87%"
        },
        {
          "id": 216993,
          "text": "MAP<70mmHg"
        },
        {
          "id": 216994,
          "text": "More than 42% infiltrates on CT"
        },
        {
          "id": 216995,
          "text": "Respiratory rate>32/minute"
        }
      ],
      "text": "Which of the following is not a criterion for COVID patient to be admitted in ICU?",
      "unique_key": "Q7411779",
      "question_audio": null,
      "question_video": null,
      "map_id": 34816080,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) ICU admission criteria for COVID-19 patients are based on clinical severity and physiological instability — not just radiological findings. Evaluation of Each Option: A. SpO2 < 87% This indicates severe hypoxemia. ICU admission is required, especially if patient is not maintaining oxygen saturation despite supplemental oxygen. ICU criterion B. MAP < 70 mmHg Indicates hemodynamic instability or shock, often requiring vasopressors and close monitoring. ICU criterion C. More than 42% infiltrates on CT CT findings alone, even if extensive (like >42% lung involvement), are not stand-alone ICU admission criteria. ICU is decided based on clinical status (e.g., oxygenation, ventilation, consciousness, BP), not solely CT changes. NOT a direct ICU criterion Correct Answer D. Respiratory rate > 32/minute Indicates respiratory distress and impending respiratory failure. This is one of the criteria for ICU admission under severe COVID-19 classification. ICU criterion",
      "correct_choice_id": 216994,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}